Author: Ravi Shankar

Delivers Record Nine-Month Net Income of $61.9 Million; Raises Quarterly Cash Dividend to $0.40 Per Share, Bringing Cumulative Dividends to $3.59 Per Share

Expands Fleet Investment Program to $855 Million – Twelve Capesize and Newcastlemax Vessels Adding 2.3 Million DWT

Highlights
(in million USD, except EPS and TCE)		Q3 2026		Q3 2025		9M 2026		9M 2025		9M YoY Growth (%)
Net Revenues		$57.5		$47.0		$155.2		$108.7		43%
Net Income		$26.0		$12.8		$61.9		$8.8		604%
Adjusted Net Income1		$27.0		$14.0		$69.0		$12.3		459%
EBITDA1		$39.4		$27.5		$102.2		$51.5		98%
Adjusted EBITDA1		$40.8		$28.9		$110.5		$55.1		100%
Fleet TCE2		$34,266		$23,476		$30,216		$19,031		59%
Earnings per share Basic & Diluted		$1.20		$0.61		$2.87		$0.42		583%
Adjusted Earnings per share Basic1		$1.25		$0.67		$3.21		$0.60		435%
Adjusted Earnings per share Diluted1		$1.25		$0.67		$3.21		$0.59		444%

Other Highlights and Developments:

Record Nine-Month Performance and Consistent Shareholder Returns

• Delivered another highly profitable quarter, bringing nine-month Net Income to a record $61.9 million, Adjusted EBITDA to $110.5 million and Adjusted EPS to $3.21.
• Declared a quarterly cash dividend of $0.40 per share, marking Seanergy’s 20th consecutive quarterly distribution.

Disciplined Fleet Renewal and Selective Growth

• Added four high-quality vessels for aggregate consideration of approximately $264 million, comprising:
  • a modern 2019-built Japanese Capesize, expected to join the fleet in January 2027;
  • a 2014-built Japanese Newcastlemax for delivery in the second half of 2029;
  • a Japanese-built Capesize newbuilding for delivery in the second half of 2029; and
  • a 210,000 dwt Newcastlemax newbuilding at Hengli, scheduled for Q1 2029.

• Agreed the sale of a 2009-built Capesize vessel for $33.0 million, expected to generate approximately $19.6 million in net liquidity and a book gain of approximately $12.4 million, closely aligning the disposal of the fleet’s oldest vessel with the deliveries of the modern 2019-built Japanese Capesize and our first newbuilding.
• The current fleet investment program now comprises twelve vessels – nine newbuildings and three Japanese-built eco secondhand Capesize and Newcastlemax vessels – totaling approximately $855 million and 2.3 million dwt, with deliveries staggered from January 2027 through 2029.
• Strong employment coverage for upcoming deliveries, with four of the six vessels scheduled for delivery in 2027–2028 having secured, or being close to securing, multi-year charters with first-class charterers, combining profitable floor rates with index-linked upside.

________________________
¹ Adjusted earnings per share, Adjusted Net Income, EBITDA and Adjusted EBITDA are non-GAAP measures. Please see the reconciliation below of Adjusted Earnings per share, Adjusted Net Income, EBITDA and Adjusted EBITDA to Net Income, the most directly comparable U.S. GAAP measure.
² Time Charter Equivalent (“TCE”) rate is a non-GAAP measure. Please see the reconciliation below of TCE rate to Net Revenues from vessels, the most directly comparable U.S. GAAP measure.

ATHENS, Greece, Nov. 12, 2026 (GLOBE NEWSWIRE) — Seanergy Maritime Holdings Corp. (“Seanergy” or the “Company”) (NASDAQ: SHIP), a leading pure-play Capesize owner and operator, today reported its financial results for the third quarter and nine months ended September 30, 2026. The Company also declared a quarterly cash dividend of $0.40 per common share, increased from the $0.35 per share declared last quarter, marking Seanergy’s 20th consecutive quarterly dividend under its capital return policy and reflecting its strong earnings generation and disciplined approach to capital allocation.

For the quarter ended September 30, 2026, the Company generated Net Revenues of $57.5 million, compared to $47.0 million in the third quarter of 2025. Net Income increased to $26.0 million from $12.8 million, while Adjusted Net Income increased to $27.0 million from $14.0 million. EBITDA and Adjusted EBITDA reached $39.4 million and $40.8 million, respectively, compared to $27.5 million and $28.9 million, respectively, for the same period of 2025. The fleet achieved a daily TCE of $34,266, representing a 46% year-over-year increase.

For the nine months ended September 30, 2026, Seanergy generated Net Revenues of $155.2 million, compared to $108.7 million in the first nine months of 2025. Net Income increased to $61.9 million from $8.8 million for the same period in 2025, while Adjusted Net Income increased to $69.0 million from $12.3 million. Adjusted EBITDA doubled to $110.5 million, and Adjusted EPS reached $3.21, compared to $0.60 for the same period in 2025. Fleet TCE increased by 59% to $30,216 per day.

Cash and cash equivalents and restricted cash, as of September 30, 2026, stood at $167.9 million. Long-term debt (senior loans and other financial liabilities, including our senior unsecured bond) net of deferred charges amounted to $409.7 million, compared with a fleet book value of $575.7 million, including advances paid for vessels under construction and a vessel under sales-type lease. Stockholders’ equity increased over the nine-month period to $333.1 million.

Stamatis Tsantanis, the Company’s Chairman & Chief Executive Officer, stated:

“Seanergy delivered another highly profitable quarter, earning a TCE of $34,266 per day, up 46% year-over-year, and bringing nine-month Net Income to a record $61.9 million and Adjusted EPS to $3.21. This performance underscores the significant operating leverage of our pure-play Capesize platform in a strong market.

“Our board of directors raised the quarterly cash dividend to $0.40 per share – double the first-quarter level – marking our 20^th consecutive distribution. Including buybacks, we have now returned approximately $117.0 million to our shareholders since the inception of our program. We are raising distributions while comfortably funding a large fleet investment program. We do not trade-off shareholder returns for growth.

“In January 2027, we expect to take delivery of the first newbuilding in Seanergy’s history, approximately four months ahead of schedule, together with the modern 2019-built Japanese Capesize M/V Midnightship. The deliveries will coincide with the planned sale of the 2009-built M/V Friendship.

“With four vessels added this quarter, representing an approximately $264 million investment, our program now comprises twelve vessels, approximately $855 million investment and 2.3 million dwt of additional capacity – expanding our fleet’s carrying capacity by more than 50%. We contracted early, and values have moved in our favor since. Based on market report valuations, the newbuilding vessels are worth approximately $85.0 million more than their contract prices, representing significant value that is not reflected on our balance sheet.

“Of the six vessels scheduled to deliver in 2027 and 2028, four have secured, or are close to securing, multi-year employment with first-class charterers. These charters combine profitable floor rates with index-linked upside, providing downside protection from delivery while retaining meaningful participation in a strong Capesize market.

“The program’s funding is progressing well, supported by strong cash reserves of $167.9 million, a staggered payment schedule with the largest instalments falling due upon the respective deliveries, and diversified sources of capital. On that basis, we remain well positioned to execute our strategy while preserving our balance sheet strength and maintaining cash distributions to our shareholders.

“Twelve vessels give us the scale, fleet profile and delivery visibility to meet our medium-term objectives. The focus shifts to execution – financing, employing and integrating these vessels as they are delivered, while preserving the flexibility to act selectively on attractive opportunities.

“The Capesize market performed strongly in the third quarter, supported by record bauxite volumes, continued growth in iron ore ton-mile demand and resilient coal trades. Market fundamentals remain constructive, underpinned by relatively limited fleet growth, an ageing Capesize fleet and increasing voyage distances driven by rising West African and Brazilian exports of iron ore and bauxite. With approximately 86% of fourth-quarter days already fixed, we expect Q4 TCE to reach approximately $33,284 per day, resulting in full-year 2026 TCE of approximately $31,000 per day, up roughly 48% compared to 2025.

“Our strategy is working: strong earnings are funding both a rising dividend and a transformational fleet renewal, while older vessels are monetized at firm market values. Seanergy enters 2027 from a position of financial and commercial strength, supported by increasing earnings, contracted cash flows, a modernizing fleet and a clear focus on enhancing long-term value per share.”

Company Fleet:

Vessel Name	Capacity (DWT)	Year Built	Yard	Scrubber Fitted	Employment Type	FFA conversion option(1)	Minimum time charter (“T/C”) expiration	Maximum T/C expiration(2)	Charterer
Titanship	207,855	2011	NACKS	–	T/C Index Linked(3)	No	09/2026	03/2027	Cargill
Meiship	207,851	2013	Imabari	–	T/C Index Linked	Yes	01/2028	06/2028	Glencore
Patriotship	181,709	2010	Imabari	Yes	T/C Index Linked	Yes	01/2028	03/2028	Glencore
Paroship	181,415	2012	Koyo -Imabari	Yes	T/C Index Linked	Yes	07/2027	12/2027	Oldendorff
Worldship	181,415	2012	Koyo – Imabari	Yes	T/C Index Linked	Yes	11/2026	03/2027	NYK
Kaizenship	181,396	2012	Koyo Dock	–	T/C Index Linked	Yes	01/2028	06/2028	Oldendorff
Iconship	181,392	2013	Imabari	–	T/C Index Linked	Yes	03/2027	07/2027	K Line
Hellasship	181,325	2012	Imabari	–	T/C Index Linked	Yes	04/2027	08/2027	NYK
Honorship	180,242	2010	Imabari	–	T/C Index Linked	Yes	03/2028	06/2028	NYK
Fellowship	179,701	2010	Daewoo	–	T/C Index Linked	Yes	01/2028	03/2028	Anglo American
Championship	179,238	2011	Sungdong	Yes	T/C Index Linked	Yes	04/2027	08/2027	Cargill
Partnership	179,213	2012	Hyundai	Yes	T/C Index Linked	Yes	01/2027	05/2027	Glencore
Knightship	178,978	2010	Hyundai	Yes	T/C Index Linked	Yes	12/2026	04/2027	Glencore
Lordship	178,838	2010	Hyundai	Yes	T/C Index Linked	Yes	01/2027	03/2027	Glencore
Blueship	178,459	2011	Mitsui	–	T/C Index Linked	Yes	12/2027	04/2028	NYK
Friendship(4)	176,952	2009	Namura	–	T/C Index Linked	Yes	04/2027	09/2027	Glencore
Flagship	176,387	2013	Mitsui	–	T/C Index Linked	Yes	10/2027	02/2028	Cargill
Premiership	170,024	2010	Sungdong	Yes	T/C Index Linked	Yes	01/2028	03/2028	Glencore
Total / Average age	3,282,390	15.3 years	–	–	–	–	–	–	–
Vessels under construction
TBN Primeship	181,000	2027	Hengli	Yes	T/C Index Linked(5)	–	5 years(6)		European Operator
TBN Chrysship	181,500	2027	Hengli	Yes	T/C Index Linked(5)	–	5 years(6)		European Operator
NB Vessel	181,500	2027	Hengli	Yes	T/C Index Linked(5)	–	4 years(7)		Major Miner
TBN Nikiship	181,500	2027	Japanese Yard	Yes	–	–	–	–	–
TBN Megaship	211,000	2028	Hantong	Yes	–	–	–	–	–
TBN Kingship	181,500	2029	Japanese Yard	Yes	–	–	–	–	–
NB Vessel	181,000	2029	Japanese Yard	Yes	–	–	–	–	–
NB Vessel	181,000	2029	Japanese Yard	Yes	–	–	–	–	–
NB Vessel	210,000	2029	Hengli	Yes	–	–	–	–	–
Vessels to be delivered
TBN	182,000	2022	Japanese Yard	–	–	–	–	–	–
TBN	210,000	2014	Japanese Yard	–	–	–	–	–	–
TBN Midnightship	180,000	2019	Japanese Yard	–	–	–	–	–	–
Bareboat charter out
Dukeship	181,453	2010	Sasebo	–	Bareboat	–	08/2027	09/2027	United

(1)	The Company has the option to convert the index-linked rate to fixed for periods ranging between 1 and 12 months, based on the prevailing Capesize FFA rate for the selected period.
(2)	The latest redelivery date does not include any additional optional periods.
(3)	The time charter agreement provides a fixed floor rate. Above the floor, the hire is calculated based on a significant premium over the BCI-180, with incremental earnings shared equally between Seanergy and the respective charterer.
(4)	The vessel is expected to be delivered to her new owners in early Q1 2027.
(5)	The time charter agreement provides a floor rate. Above the floor, the hire is calculated at a significant premium over the BCI-180 up to an upper threshold, and above the upper threshold, the hire is calculated based on the same premium over the BCI-180, with incremental earnings shared equally between Seanergy and the respective charterer.
(6)	The time charter agreement provides three optional extension periods of minimum 10 to maximum 14 months each.
(7)	The time charter agreement provides two optional extension periods of about 11 to about 13 months each.

Fleet Data:

(U.S. Dollars in thousands)

	Q3 2026		Q3 2025		9M 2026		9M 2025
Ownership days (1)	1,656		1,911		5,115		5,600
Operating days (2)	1,634		1,856		4,990		5,363
Fleet utilization (3)	98.7%		97.1%		97.6%		95.8%
TCE rate (4)	$34,266		$23,476		$30,216		$19,031
Daily Vessel Operating Expenses (5)	$6,699		$7,376		$6,999		$7,086

(1)	Ownership days are the total number of calendar days in a period during which the vessels in a fleet have been owned or chartered in. Ownership days are an indicator of the size of the Company’s fleet over a period and affect both the amount of revenues and the amount of expenses that the Company recorded during a period.
(2)	Operating days are the number of available days in a period less the aggregate number of days that the vessels are off-hire due to unforeseen circumstances. Available days are the number of ownership days less the aggregate number of days that our vessels are off-hire due to major repairs, dry-dockings, lay-up or special or intermediate surveys. Operating days include the days that our vessels are in ballast voyages without having finalized agreements for their next employment. The Company’s calculation of operating days may not be comparable to that reported by other companies.
(3)	Fleet utilization is the percentage of time that the vessels are generating revenue and is determined by dividing operating days by ownership days for the relevant period. Fleet Utilization is used to measure a company’s ability to efficiently find suitable employment for its vessels and minimize the number of days that its vessels are off-hire for unforeseen events. We believe it provides additional meaningful information and assists management in making decisions regarding areas where we may be able to improve efficiency and increase revenue and because we believe that it provides useful information to investors regarding the efficiency of our operations. The Company’s calculation of fleet utilization may not be comparable to that reported by other companies.
(4)	TCE rate is defined as the Company’s net vessel revenue less voyage expenses during a period divided by the number of the Company’s operating days during the period. Voyage expenses include port charges, bunker (fuel oil and diesel oil) expenses, canal charges and other commissions. The Company includes the TCE rate, which is not a recognized measure under U.S. GAAP, as it believes it provides additional meaningful information in conjunction with net revenues from vessels, the most directly comparable U.S. GAAP measure, and because it assists the Company’s management in making decisions regarding the deployment and use of our vessels and because the Company believes that it provides useful information to investors regarding our financial performance. The Company’s calculation of TCE rate may not be comparable to that reported by other companies. The following table reconciles the Company’s net revenues from vessels to the TCE rate.

(In thousands of U.S. Dollars, except operating days and TCE rate)

	Q3 2026	Q3 2025	9M 2026	9M 2025
Vessel revenue, net	56,800	46,126	153,544	106,466
Less: Voyage expenses	809	2,555	2,767	4,402
Time charter equivalent revenues	55,991	43,571	150,777	102,064
Operating days	1,634	1,856	4,990	5,363
TCE rate	$34,266	$23,476	$30,216	$19,031

(5)

Vessel operating expenses include crew costs, provisions, deck and engine stores, lubricants, insurance, maintenance and repairs. Daily Vessel Operating Expenses are calculated by dividing vessel operating expenses, excluding pre delivery costs, by ownership days for the relevant time periods. The Company’s calculation of daily vessel operating expenses may not be comparable to that reported by other companies. The following table reconciles the Company’s vessel operating expenses to daily vessel operating expenses.

(In thousands of U.S. Dollars, except ownership days and Daily Vessel Operating Expenses)

	Q3 2026	Q3 2025	9M 2026	9M 2025
Vessel operating expenses	11,094	14,095	35,800	40,441
Less: Pre-delivery expenses	–	–	–	757
Vessel operating expenses before pre-delivery expenses	11,094	14,095	35,800	39,684
Ownership days	1,656	1,911	5,115	5,600
Daily Vessel Operating Expenses	$6,699	$7,376	$6,999	$7,086

Net income to EBITDA and Adjusted EBITDA Reconciliation:

(In thousands of U.S. Dollars)

	Q3 2026		Q3 2025		9M 2026		9M 2025
Net income	25,965		12,752		61,859		8,785
Interest and finance cost, net	4,141		5,378		12,280		15,943
Depreciation and amortization	9,280		9,415		28,077		26,792
EBITDA	39,386		27,545		102,216		51,520
Stock based compensation	1,648		1,026		6,166		3,703
Loss on extinguishment of debt	417		63		2,589		91
Loss on forward freight agreements, net	16		35		26		54
(Gain) / loss on FX derivatives	(20	)	192		94		(231	)
Unrealized gain on equity securities	(36	)	–		(36	)	–
Unrealized FX gain on unsecured bond	(600	)	–		(600	)	–
Adjusted EBITDA	40,811		28,861		110,455		55,137

Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) represents the sum of net income, net interest and finance costs, depreciation and amortization and, if any, income taxes during a period. EBITDA and Adjusted EBITDA are not recognized measurements under U.S. GAAP. Adjusted EBITDA represents EBITDA adjusted to exclude stock-based compensation, loss on forward freight agreements, net, loss on extinguishment of debt, (gain) / loss on FX derivatives, unrealized gain on equity securities and unrealized FX gain on unsecured bond which the Company believes are not indicative of the ongoing performance of its core operations.

EBITDA and adjusted EBITDA are presented as we believe that these measures are useful to investors as a widely used means of evaluating operating profitability from period to period. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating the Company’s performance. EBITDA and adjusted EBITDA as presented here may not be comparable to similarly titled measures presented by other companies. These non-GAAP measures should not be considered in isolation from, as a substitute for, or superior to, financial measures prepared in accordance with U.S. GAAP.

Adjusted Net Income Reconciliation and calculation of Adjusted Earnings Per Share

(In thousands of U.S. Dollars, except for share and per share data)

	Q3 2026		Q3 2025		9M 2026		9M 2025
Net income	25,965		12,752		61,859		8,785
Stock based compensation	1,648		1,026		6,166		3,703
Loss on extinguishment of debt (non-cash)	83		63		1,524		81
(Gain) / loss on FX derivatives	(20	)	192		94		(231	)
Unrealized gain on equity securities	(36	)	–		(36	)	–
Unrealized FX gain on unsecured bond	(600	)	–		(600	)	–
Adjusted net income	27,040		14,033		69,007		12,338
Dividends to non-vested participating securities	(171	)	(25	)	(348	)	(91	)
Undistributed earnings to non-vested participating securities	(416	)	(282	)	(984	)	(102	)
Adjusted net income – common shareholders	26,453		13,726		67,675		12,145
Adjusted earnings per common share, basic	1.25		0.67		3.21		0.60
Adjusted earnings per share, diluted	1.25		0.67		3.21		0.59
Weighted average number of common shares outstanding, basic	21,177,455		20,493,231		21,072,954		20,336,137
Weighted average number of common shares outstanding, diluted	21,177,455		20,562,616		21,072,954		20,425,195

To derive Adjusted Net Income and Adjusted Earnings Per Share, a non-GAAP financial measure, from Net Income, we adjust for dividends and undistributed earnings to non-vested participating securities and exclude non-cash items, as provided in the table above. We believe that Adjusted Net Income and Adjusted Earnings Per Share assist our management and investors by increasing the comparability of our performance from period to period since each such measure eliminates the effects of such non-cash items as loss on extinguishment of debt, stock based compensation, (gain) / loss on FX derivatives, unrealized gain on equity securities, unrealized FX gain on unsecured bond and other items which may vary from year to year, for reasons unrelated to overall operating performance. In addition, we believe that the presentation of the respective measure provides investors with supplemental data relating to our results of operations, and therefore, with a more complete understanding of factors affecting our business than with GAAP measures alone. Our method of computing Adjusted Net Income and Adjusted Earnings Per Share may not necessarily be comparable to other similarly titled captions of other companies due to differences in methods of calculation.

Fourth Quarter 2026 TCE Rate Guidance:

As of the date hereof, approximately 86% of the Company fleet’s expected operating days in the fourth quarter of 2026 have been fixed at an estimated TCE rate of approximately $32,923. Assuming that for the remaining operating days of our index-linked time charters, the BCI-180 rate will be equal to $37,968 (based on the FFA curve as of November 5, 2026), our estimated TCE rate for the fourth quarter of 2026 will be approximately $33,284³. The following table provides the breakdown of index-linked charters and fixed-rate charters in the fourth quarter of 2026:

	Operating Days	TCE
TCE – fixed rate (incl. FFA conversions)	1,195	$32,254
TCE – index-linked	435	$36,109
Total / Average	1,630	$33,284

________________________
³ This guidance is based on certain assumptions and the Company cannot provide assurance that these TCE rate estimates, or projected utilization rates will be realized. TCE estimates include certain floating (index) to fixed rate conversions concluded in previous periods. For vessels on index-linked T/Cs, the TCE rate realized will vary with the underlying index, and for the purposes of this guidance, the BCI 5TC 180 rate assumed for the remaining operating days of the quarter for index-linked T/Cs is equal to $37,968 (based on the FFA curve as of November 5, 2026). Spot estimates are provided using the load-to-discharge method of accounting. The rates quoted are for days currently contracted. Increased ballast days at the end of the quarter will reduce the additional revenues that can be booked based on the accounting cut-offs and therefore the resulting TCE rate will be reduced accordingly.

Third Quarter and Recent Developments:

Dividend Distribution for Q2 2026 and Declaration of Q3 2026 Dividend

On October 9, 2026, the Company paid a quarterly cash dividend of $0.35 per common share for the second quarter of 2026 to all shareholders of record as of September 25, 2026.

The Company has declared a quarterly cash dividend of $0.40 per common share for the third quarter of 2026 payable on or about January 8, 2027, to all shareholders of record as of December 24, 2026.

Fleet Update

Acquisition of Four Vessels for Delivery Between 2027 and 2029

Since its previous quarterly update, the Company has agreed to acquire four vessels from unaffiliated third parties for an aggregate consideration of approximately $264 million, comprising:

• a 180,000 dwt Capesize built in 2019 in Japan, to be renamed M/V Midnightship, expected to be delivered in January 2027 and to be funded through cash on hand and debt financing;
• a 210,000 dwt scrubber-fitted Newcastlemax newbuilding, contracted in July 2026 with Hengli Shipbuilding (Dalian) Co., Ltd. and Hengli Shipbuilding (Singapore) Pte. Ltd., with delivery expected in the first quarter of 2029;
• a 181,000 dwt scrubber-fitted Capesize newbuilding at a Japanese shipyard, with delivery expected in the second half of 2029; and
• a 210,000 dwt Newcastlemax built in 2014 in Japan, with delivery expected in the second half of 2029.

For the 2019-built Capesize, the Company has paid a 10% deposit, with the remaining 90% payable upon delivery. The contract price of the Hengli newbuilding is payable in five instalments linked to construction milestones, with 60% payable upon delivery. For the Japanese Capesize newbuilding, the Company has paid the first instalment of the purchase price, with 35% payable in three instalments linked to construction milestones and 60% payable upon delivery. For the 2014-built Newcastlemax, the agreement provides for a 10% deposit, with the remaining 90% payable upon delivery.

The newbuildings will incorporate eco-design features, enhancing fuel efficiency and reducing emissions in line with the Company’s fleet renewal and decarbonization strategy.

Advances Towards the Ship Investment Program

Including the four additional vessels, the Company’s total investment program currently stands at $855 million. To date, the Company has paid $127.4 million towards its fleet investment program. The remaining commitments of approximately $727.6 million are staggered through 2029, with the largest instalments payable upon delivery of the respective vessels, and are expected to be funded through a combination of existing liquidity, including cash and restricted cash of $167.9 million as of September 30, 2026, operating cash flow, committed and future vessel financing and proceeds from selective vessel disposals.

Sale of M/V Friendship

In November 2026, the Company agreed on the main terms to sell the M/V Friendship to United Maritime Corporation (“United”), a related party, for an aggregate purchase price of $33.0 million. The sale is subject to the existing financier’s approval and the parties entering into final documentation, with delivery expected in early Q1 2027. A special committee of independent and disinterested members of the Company’s board of directors negotiated and approved the terms.

The transaction is expected to generate net cash proceeds of approximately $19.6 million, supporting the Company’s ongoing fleet renewal program, while reducing Seanergy’s average fleet age. The sale is also expected to result in a book gain of approximately $12.4 million, to be recognized upon delivery of the vessel in the first quarter of 2027. Following delivery, Seanergy will continue to provide technical and commercial management services to the vessel.

Commercial Updates

M/V Premiership – Time Charter Extension

In September 2026, the time charter agreement for the M/V Premiership was extended until minimum January 2028 and maximum March 2028, in direct continuation from the previous agreement. The revised daily hire is based on the 5 T/C routes of the BCI, while all other main terms of the time charter remain materially the same.

M/V Patriotship – Time Charter Extension

In November 2026, the time charter agreement for M/V Patriotship was extended until minimum January 2028 and maximum March 2028, in direct continuation from the previous agreement. The revised daily hire is based on the 5 T/C routes of the BCI, with retroactive effect from January 2026, while all other main terms of the time charter remain materially the same.

Conference Call:

The Company’s management will host a conference call to discuss financial results on November 12, 2026, at 10:00 a.m. Eastern Time.

Audio Webcast:

There will be a live, and then archived, webcast of the conference call available through the Company’s website. To listen to the archived audio file, visit our website, following the Webcast & Presentations section under our Investor Relations page. Participants to the live webcast should register on Seanergy’s website approximately 10 minutes prior to the start of the webcast, following this link.

Conference Call Details:

Participants have the option to register for the call using the following link. You can use any number from the list or add your phone number and let the system call you right away.

Seanergy Maritime Holdings Corp. Unaudited Condensed Consolidated Balance Sheets (In thousands of U.S. Dollars)
		September 30, 2026			December 31, 2025*
ASSETS
Cash and cash equivalents and restricted cash		167,944			62,653
Vessels, net, vessels under construction, advances for vessel acquisition, finance lease prepayment and sales type leases		575,674			506,660
Other assets		38,277			37,266
TOTAL ASSETS		781,895			606,579
LIABILITIES AND STOCKHOLDERS’ EQUITY
Long-term debt and other financial liabilities, net of deferred finance costs		409,726			290,160
Other liabilities		39,030			35,036
Stockholders’ equity		333,139			281,383
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY		781,895			606,579

* Derived from the audited consolidated financial statements as of that date

Seanergy Maritime Holdings Corp. Unaudited Condensed Consolidated Statements of Operations (In thousands of U.S. Dollars, except for share and per share data, unless otherwise stated)
		Three months ended September 30,				Nine months ended September 30,
		2026		2025		2026			2025
Vessel revenue, net		56,800		46,126		153,544			106,466
Fees from related parties		652		866		1,701			2,211
Revenue, net		57,452		46,992		155,245			108,677
Expenses:
Voyage expenses		(809	)	(2,555	)	(2,767	)		(4,402	)
Vessel operating expenses		(11,094	)	(14,095	)	(35,800	)		(40,441	)
Management fees		(225	)	(279	)	(745	)		(831	)
General and administrative expenses		(6,187	)	(4,629	)	(20,352	)		(13,641	)
Depreciation and amortization		(9,280	)	(9,415	)	(28,077	)		(26,792	)
Gain on sales type leases		–		–		4,101			–
Gain on sale of vessel		–		2,308		4,559			2,308
Loss on forward freight agreements, net		(16	)	(35	)	(26	)		(54	)
Operating income		29,841		18,292		76,138			24,824
Other income / (expenses):
Interest and finance costs		(5,114	)	(5,566	)	(14,253	)		(16,496	)
Loss on extinguishment of debt		(417	)	(63	)	(2,589	)		(91	)
Interest and other income		837		193		1,570			530
Interest and other income – related party		182		–		464			48
Other, net		636		(104	)	529			(30	)
Total other expenses, net:		(3,876	)	(5,540	)	(14,279	)		(16,039	)
Net income		25,965		12,752		61,859			8,785
Net income attributable to common shareholders		25,378		12,445		60,527			8,592
Net income per common share, basic and diluted		1.20		0.61		2.87			0.42
Weighted average number of common shares outstanding, basic		21,177,455		20,493,231		21,072,954			20,336,137
Weighted average number of common shares outstanding, diluted		21,177,455		20,562,616		21,072,954			20,425,195

Seanergy Maritime Holdings Corp. Unaudited Condensed Consolidated Cash Flow Data (In thousands of U.S. Dollars)
		Nine months ended September 30,
		2026		2025
Net cash provided by operating activities		82,219		25,819
Vessels acquisitions and improvements		(3,029	)	(34,401	)
Advance for vessel acquisition		(4,950	)	–
Vessels under construction		(102,170	)	–
Loan to related party		–		(2,000	)
Repayment of loan by related party		–		2,000
Finance lease prepayments and other initial direct costs		(3,883	)	(8,150	)
Investment in equity securities		(924	)	–
Proceeds from sale of assets		13,813		21,590
Due from related parties		2,466		(188	)
Net cash used in investing activities		(98,677	)	(21,149	)
Proceeds from long-term debt and other financial liabilities		255,100		110,560
Repayments of long-term debt and other financial liabilities		(114,184	)	(80,120	)
Payments of financing and stock issuance costs		(8,760	)	(2,045	)
Payments of finance lease liabilities		–		(23,747	)
Proceeds from other non-current liabilities		1,004		166
Dividends payments		(11,412	)	(8,433	)
Proceeds from issuance of common stocks and warrants, net of underwriters fees and commissions		–		845
Net cash provided by / (used in) financing activities		121,748		(2,774	)
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid during the period for interest, net of capitalized interest		9,509		15,893
Noncash investing activities
Vessels’ improvements		810		263
Other financial liabilities assumed by buyer upon sale of vessel		15,687		–
Vessels under construction		532		–
Noncash financing activities
Dividends declared but not paid		7,584		1,056
Financing and stock issuance costs		2,013		78
Other financial liabilities assumed by buyer upon sale of vessel		(15,687	)	–

About Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp. is a prominent pure-play Capesize shipping company publicly listed in the U.S. Seanergy provides marine dry bulk transportation services through a modern fleet of Capesize vessels. The Company owns or operates under finance leases 19 vessels (2 Newcastlemax and 17 Capesize) with an average age of approximately 15.3 years and an aggregate cargo carrying capacity of 3,463,843 dwt. Upon the sale of the M/Vs Dukeship and Friendship and the delivery of the nine newbuilding vessels and three secondhand vessels, the Company will own or operate under finance leases 29 vessels (5 Newcastlemax and 24 Capesize), with an aggregate cargo carrying capacity of approximately 5,367,438 dwt.

The Company is incorporated in the Republic of the Marshall Islands and has executive offices in Glyfada, Greece. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “SHIP”.

Please visit our Company website at: www.seanergymaritime.com.

Forward-Looking Statements

This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, including with respect to declaration of dividends, market trends and shareholder returns. Words such as “may”, “should”, “expects”, “intends”, “plans”, “believes”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company’s operating or financial results; the Company’s liquidity, including its ability to service its indebtedness; competitive factors in the market in which the Company operates; shipping industry trends, including charter rates, vessel values and factors affecting vessel supply and demand; future, pending or recent acquisitions and dispositions, business strategy, impacts of litigation, areas of possible expansion or contraction, and expected capital spending or operating expenses; risks associated with operations outside the United States; risks arising from trade disputes between the U.S. and China, including the re-imposition of reciprocal port fees; broader market impacts arising from trade disputes or war (or threatened war) or international hostilities, such as between the U.S. and Israel and Iran, the U.S. and Venezuela, China and Taiwan and Russia and Ukraine; risks associated with the length and severity of pandemics; and other factors listed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”), including its most recent annual report on Form 20-F. The Company’s filings can be obtained free of charge on the SEC’s website at www.sec.gov. Except to the extent required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

For further information please contact:

Seanergy Investor Relations
Tel: +30 213 0181 522
E-mail: ir@seanergy.gr

Capital Link, Inc.
Paul Lampoutis
230 Park Avenue Suite 1540
New York, NY 10169
Tel: +1 212 661 7566
E-mail: seanergy@capitallink.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/faee33af-960d-4b38-a5b5-039cbf064d45

Analysis shows IT salaries rising 2.1% year over year with demand driven by employers in healthcare, manufacturing, government and financial services

Facts at a Glance:

• In-demand roles such as Senior Cybersecurity Architect saw salary increases of up to 22% year over year.
• Most tech workers are now employed at non-tech companies.
• The median tech wage is 126% higher than the national average.

TROY, Mich., Nov. 12, 2026 (GLOBE NEWSWIRE) — Technology staffing and solutions leader Motion Recruitment, a Kelly^® (Nasdaq: KELYA, KELYB) company, has published its 2027 Tech Salary Guide, offering workforce trends and compensation data for the most in-demand IT roles. The guide finds that tech salaries have increased 2.1% year over year, with stronger gains in specialized roles, as today’s technology labor market is increasingly shaped by AI investment, shifting skill requirements and demand beyond traditional tech companies.

The tenth annual report analyzes thousands of job postings and real-time market data. It features insights from industry leaders to help employers and job seekers separate what is driving the market from what is making headlines.

Tech Pay Rises Modestly as Demand Shifts Beyond Tech Companies

Average tech salaries in the United States rose 2.1%, according to Motion’s analysis, but salary increases vary sharply by specialty and region:

• Senior Cybersecurity Architects saw a 22% year-over-year increase, while Network Security Engineers averaged 14% growth and Application Developers saw an average of 10% growth. AI Engineers saw an average increase of 8%.
• Salary increases differed across regions, with Atlanta (12%), Dallas (11%), Charlotte (10%) and Phoenix (10%) seeing some of the largest percentage annual gains.

“AI and emerging technologies are changing the mix of specialized expertise companies need, from software and data to cybersecurity, cloud and infrastructure,” said Motion Recruitment President James Vallone. “For employers, the strategic challenge is connecting those capabilities to turn investment into reliable, scalable systems. That means planning beyond your next hire to identify the skills, team structure and project delivery support needed to move from experimentation to execution.”

These compensation trends sit within an IT workforce that extends well beyond tech companies. Only about 40% of tech workers are employed directly by technology companies, with healthcare, manufacturing, government and financial services now employing the majority of tech workers. Hiring signals inside and outside the tech industry are pointing in different directions:

• Tech companies cut more than 122,000 jobs through mid-2026, and employment within the tech industry has declined for 16 consecutive months.
• However, net tech employment is projected at 9.8 million, up 200,000 from the previous year.
• IT job postings grew from fewer than 380,000 in January to more than 629,000 in October.

AI-Driven Layoffs Face Growing Scrutiny

Early assumptions about AI replacing workers are being reconsidered. A Morning Consult survey commissioned by Kelly found only 10% of employers are cutting headcount because of AI, while 39% are redistributing tasks and 20% are adding staff. Other research highlights the challenges:

• 55% of employers now say they regret decisions around AI-related layoffs.
• Half of companies that cited AI for headcount reductions are projected to rehire for similar functions by 2027, though often under offshore roles, new titles or lower-level positions.
• Only 7% of business leaders report having established ROI from their AI investments.

“Employers need to assess not only what AI can do, but also the infrastructure, oversight and skills needed to make it effective,” Vallone said. “Before making workforce decisions, IT leaders should be clear about what they expect AI to deliver, who is accountable for the results and where human expertise remains essential. AI is a force multiplier, not a one-to-one replacement.”

AI Fluency Becomes a Baseline While the Entry-Level Ladder Narrows

Employers now require AI competency for over one third of entry-level jobs. Early-career professionals face a difficult combination of higher AI skill expectations with fewer opportunities to build applied experience on the job.

• 75% of U.S. tech job postings require AI skills.
• Active listings for roles requiring AI capabilities grew from nearly 275,000 in January to more than 366,000 in October.
• 35% of entry-level jobs now require AI competency.

Meanwhile, employers and talent disagree on the level of AI training provided. The Kelly survey found 44% of employers say they did a great deal to train employees on AI, while 50% of employed workers say their company has done nothing. AI is also complicating how employers screen candidates, with a recent survey finding 40% of hiring managers have interviewed a candidate later revealed to be using a fake identity.

“Employers want people who can contribute quickly, but they also need to build the talent they’ll depend on next,” Vallone said. “Early-career candidates who can explain, test and improve what they built with AI deserve a closer look. The challenge is creating room to develop sound technical judgment, even as teams face pressure to do more with less.”

AI Demand Creates a Chain Reaction Across Emerging Tech and Infrastructure

AI adoption is driving demand for specialized talent beyond AI itself, including cloud, semiconductors, data centers and power infrastructure. Organizations report being understaffed in AI (47%), cybersecurity (40%) and platform engineering (34%), while 61% of organizations report inadequate quantum skills. The U.S. also faces a projected shortage of up to 157,000 semiconductor workers by 2030. As AI investment accelerates, these interconnected talent gaps present a growing challenge.

The 2027 Tech Salary Guide offers employers and tech professionals a comprehensive look at market trends, emerging specialties and compensation data alongside practical hiring and career advice. To explore the full report, access the 2027 Tech Salary Guide here.

About Motion’s 2027 Tech Salary Guide

Motion Recruitment’s 2027 Tech Salary Guide provides compensation data, market insights and expert advice to support workforce planning, budget alignment and career development. The guide is built from Motion’s proprietary data, verified job placements and employer demand trends, supplemented by third-party research and real-time labor market intelligence across the United States.

About Motion Recruitment

Motion Recruitment, a Kelly^® company, helps organizations accelerate their most important technology initiatives through specialized talent, consulting and project-based solutions. As the leader of Kelly’s technology division, Motion connects companies with hard-to-find expertise across software, data, AI, cloud, product, cybersecurity and other high-demand technology disciplines, delivering flexible solutions that range from contract staffing and direct hire to project and program delivery. Through Motion Consulting Group, clients can go beyond traditional staffing to access strategic consulting, digital transformation, and outcome-based solutions. Motion is also the creator of Tech in Motion, a North American technology networking and awards program connecting more than 350,000 tech enthusiasts. As part of Kelly’s evolving specialty portfolio, Motion Recruitment and Motion Consulting Group will come together under Kelly Technology in 2027.

About Kelly^®

At Kelly® (Nasdaq: KELYA, KELYB), we don’t just understand the future of work, we’re defining it. For over 80 years, we’ve sourced specialized talent, built agile workforces, and shaped growth strategies for employers around the world. Today, our recruiting, outsourcing, and consulting services provide the talent and solutions organizations need to move faster and grow smarter. We deliver meaningful impact by connecting people to work that enriches their lives, and companies to people who drive innovation and growth. Each year, we place more than 375,000 job seekers in new roles spanning science, engineering, technology, telecom, education, manufacturing, and more.

Media Contact

Christian Taske
248-561-8823
christian.taske@kellyservices.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f202c771-a7e2-434e-9bf0-c17ef5aedd73

This press release was published by a CLEAR® Verified individual.

Preliminary Figures Show Two Months of Growth Entirely from the Established Stationary Portfolio, with ROAMEO, SARA and RAIA Representing Future Growth Opportunities

Detroit, Michigan, Nov. 12, 2026 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a developer and operator of AI-driven security and productivity solutions for enterprise clients, today announced that its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), grew billed recurring monthly revenue (billed RMR) by 12.4% over two months, with all growth generated by its stationary device portfolio. Billed RMR reached $663,906 in October 2026, up $73,409 from $590,497 in August 2026. October’s billing level represents an annualized billed recurring revenue run rate of nearly $8.0 million. These preliminary, unaudited figures are based on the Company’s internal accounting records and may change upon completion of the Company’s quarterly review.

RAD’s billed RMR growth accelerated during the first two months of the Company’s third fiscal quarter, which runs from September through November 2026. Billed RMR increased $33,804, or 5.7%, in September and $39,605, or 6.3%, in October. October delivered both a larger dollar increase and a higher percentage gain on an already expanded recurring billing base.

“Our core stationary business is delivering, with October producing an even stronger increase in recurring billings than September,” said Steve Reinharz, CEO/CTO and founder of AITX and RAD. “We are expanding the recurring billing base while lowering the cost of operating the business. That is progress on both sides of the equation, and it is how we intend to close the gap to positive operational cash flow.”

The entire increase was generated by RAD’s standard stationary device portfolio, strengthening the Company’s established recurring subscription base. This growth was achieved without contributions from ROAMEO^™, SARA^™ or RAIA^™, which the Company views as future growth opportunities.

“Our stationary business is building the recurring revenue foundation for our next stage of growth,” Reinharz added. “As we outlined in our November 10 roadmap update, we are concentrating engineering resources on SARA, RAIA and the continued advancement of ROAMEO. We see these as three pillars of future growth, supported by an established business that is delivering results today. Leadership means making hard choices about priorities and having the resolve to see them through. We have made those choices, and we are determined to turn that focus into a larger, stronger recurring revenue business.”

About Billed RMR
Billed RMR is the net recurring subscription revenue billed to customers each month and collectible under standard payment terms. RAD primarily offers its solutions through monthly subscriptions, typically with a minimum contract term of 12 months.

Billed RMR is an operating metric, is not prepared in accordance with U.S. GAAP and has not been reconciled to any GAAP measure in this release. It is not a substitute for revenue reported in the Company’s financial statements.

The billed RMR figures in this release are preliminary and unaudited, based on the Company’s internal accounting records and subject to change upon completion of its quarterly review. Final figures may differ materially.

About Artificial Intelligence Technology Solutions, Inc. (AITX) 
AITX is a developer and provider of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and drive operational efficiency. Through its family of companies, including PURSUON, Inc. (formerly RAD-M), Robotic Assistance Devices, Inc. (RAD-I), Robotic Assistance Devices Residential (RAD-R), Robotic Assistance Devices Group (RAD-G), and Robotic Assistance Devices Lanka (Private) Limited (RAD Lanka), AITX develops and delivers a broad range of AI-driven technologies and services designed to transform security, automation, and operational workflows across multiple industries.

Through its primary subsidiary, RAD-I, AITX is redefining the nearly $50 billion U.S. security and guarding services industry¹ with its AI-driven Solutions-as-a-Service model. RAD solutions are specifically designed to deliver cost savings of between 35% and 80% compared to traditional manned security and monitoring, utilizing a suite of stationary and mobile autonomous systems that complement, and in many cases replace, human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are primarily developed in-house.

All of RAD’s solutions are designed to integrate with leading industry platforms and workflows, including an integration with Immix^®, a provider of central station and remote monitoring software.

The Company has completed a SOC 2 Type 2 examination covering the controls, system scope and review period described in the related report, a form of independent attestation frequently requested by enterprise and government clients that require documented data protection and compliance practices.

AITX is led by Steve Reinharz, CEO/CTO and founder of the Company and all subsidiaries, who brings decades of experience in the security services industry. The broader AITX leadership and its subsidiaries draw on deep expertise across security, law enforcement, and robotics innovation, supporting the Company’s ability to deliver practical and scalable solutions.

The Company’s solutions are deployed across a wide range of industries including enterprises, government, transportation, critical infrastructure, education, and healthcare.

To learn more, visit www.aitx.ai, www.radsecurity.com, www.pursuon.com, www.radgroup.ai, www.saramonitoring.ai, www.radlightmyway.com, and www.stevereinharz.com, or follow Steve Reinharz on X @SteveReinharz. Information contained on, or accessible through, the foregoing websites and social media accounts is not incorporated by reference into, and does not form a part of, this press release or any of the Company’s filings with the Securities and Exchange Commission.

Cautionary Disclosure About Forward Looking Statements
This press release contains forward looking statements, including statements regarding continued growth in billed recurring monthly revenue; the future contributions of the Company’s stationary device portfolio, ROAMEO, SARA and RAIA; the anticipated benefits of concentrating engineering resources on those programs; expected operating cost reductions; the Company’s internal targets for monthly operating cash breakeven; the Company’s efforts to narrow the gap to positive operational cash flow and build a larger recurring revenue business.

These statements reflect management’s current expectations and assumptions and are subject to significant risks and uncertainties. Actual results may differ materially. The growth reported for September and October 2026 may not continue, and the Company may not achieve or sustain positive operational cash flow.

The annualized billed recurring revenue run rate presented in this release is calculated by multiplying October 2026 billed RMR by 12. It illustrates the annual equivalent of that month’s billing level and is not a forecast of annual billings, revenue recognized under U.S. GAAP or cash collections. Billed amounts may not be collected when anticipated or in full. The underlying figures are preliminary and unaudited and may change materially following the Company’s quarterly review.

Risks include customer concentration of the Company’s revenue in its largest customer, which has reduced its spending since December 2025, cancellations or non-renewals; delays in deployments, billing or collections; changes in pricing, product mix or margins; development, integration, production or commercialization delays; customer adoption below expectations; cost reductions being delayed, smaller than anticipated or offset by other expenditures; staffing or resource reductions affecting execution, service or retention; and debt service, inventory purchases, deferred compensation and other cash requirements exceeding expectations. The availability and terms of financing may also affect the Company’s ability to execute its plans.

Readers should not place undue reliance on forward looking statements, which speak only as of the date of this release. Except as required by law, the Company undertakes no obligation to update them. This release does not constitute an offer to sell or the solicitation of an offer to buy securities. The Company does not qualify for the statutory safe harbor for forward looking statements under the Private Securities Litigation Reform Act of 1995.

Certain Information Regarding the Company’s Financial Condition
The Company has not been profitable in any fiscal year of its operating history and has reported significant operating losses, negative working capital and a stockholders’ deficit. Its independent auditor’s report expresses substantial doubt regarding its ability to continue as a going concern. The Company’s cash on hand is insufficient to fund operations for an extended period without additional financing. Such financing may not be available on acceptable terms or at all and may substantially dilute existing stockholders.

The Company’s previously described operating cash breakeven measure compares recognized revenue with operating cash payments and excludes debt service and inventory purchases for device builds. Progress toward that objective does not establish GAAP profitability or eliminate financing needs, deferred obligations or other cash requirements.

Investors should review the Company’s Annual Report for the fiscal year ended February 28, 2026, as amended, its Quarterly Report for the period ended August 31, 2026, and subsequent filings with the Securities and Exchange Commission for additional information regarding its financial condition, financing arrangements and risks.

###

Doug Clemons, Chief Marketing Officer
248-270-8273
doug.c@radsecurity.com 

---

¹ https://www.ibisworld.com/united-states/market-research-reports/security-services-industry/

Patent strengthens intellectual property protection for preparation of preliposomal Annamycin lyophilizate

HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced the grant of an Australian patent covering the preparation of preliposomal Annamycin lyophilizate, strengthening the Company’s intellectual property protection for a key aspect of Annamycin’s formulation technology.

Australian Patent No. 2020303572 was granted to Moleculin and The Board of Regents of The University of Texas System. The patent titled, “Preparation of Preliposomal Annamycin Lyophilizate,” addresses the preparation of Annamycin’s formulation.

“Securing this patent in Australia represents another step in our efforts to build a strong international intellectual property position around Annamycin,” said Walter Klemp, Chairman and Chief Executive Officer of Moleculin. “Our formulation technology is an important component of Annamycin’s development, and protecting this technology across international markets supports our broader intellectual property strategy.”

Expanding International Protection for Annamycin Formulation Technology

The Australian patent is part of Moleculin’s broader global intellectual property portfolio covering complementary technologies associated with Annamycin, the Company’s investigational anthracycline.

The patent portfolio includes granted or allowed patents in the United States, Canada, China, Europe, India, Israel, Japan, Mexico, Singapore and Taiwan. The application has also been accepted in South Africa, where formal grant is pending, while applications remain pending in additional jurisdictions, including South Korea.

Moleculin’s global patent strategy also encompasses additional technology areas, including methods for reconstituting liposomal Annamycin and lung-targeted anticancer therapies using liposomal Annamycin. Together, these efforts reflect the Company’s focus on establishing intellectual property protection across multiple aspects of Annamycin’s development and in key international markets.

Annamycin is an investigational anthracycline designed to address limitations associated with conventional anthracyclines. The drug candidate is being evaluated in clinical development for acute myeloid leukemia (AML) and other difficult-to-treat cancers.

About Moleculin Biotech, Inc.

Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company’s lead program, Annamycin (also known as naxtarubicin), has shown to be an efficacious and well tolerated anthracycline designed to avoid multidrug resistance mechanisms and to lack the cardiotoxicity common with currently prescribed anthracyclines. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.

The Company is conducting the MIRACLE (Moleculin R/R AML AnnAraC Clinical Evaluation) Trial (MB-108), a pivotal, adaptive design, multi-center, randomized, double-blind, placebo-controlled Phase 2/3 trial evaluating Annamycin in combination with cytarabine (also referred to as “Ara-C”), together referred to as AnnAraC, for the treatment of relapsed or refractory acute myeloid leukemia. Following a successful Phase 1B/2 study (MB-106), with input from the FDA, the Company believes it has substantially de-risked the development pathway toward a potential approval for Annamycin for the treatment of AML. This study remains subject to appropriate future filings with potential additional feedback from the FDA and their foreign equivalents.

Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers. Moleculin also has in its pipeline a portfolio of antimetabolites, including WP1122 for the potential treatment of pathogenic viruses, as well as certain cancer indications.

For more information about the Company, please visit www.moleculin.com and connect on X, LinkedIn and Facebook.

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the potential efficacy and safety of Annamycin and AnnAraC in R/R AML, the strength and scope of the Company’s intellectual property portfolio, the Company’s ability to obtain and enforce patent protection in various jurisdictions, and the anticipated advancement of the MIRACLE trial toward potential registration. Moleculin will require significant additional financing, for which the Company has no commitments, in order to conduct its clinical trials as described in this press release, and the ability to complete such trials assumes the Company’s ability to secure such financing on a timely basis. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company relies on the reports of its expert with regard to the absence of cardiotoxicity. Moleculin has attempted to identify forward-looking statements by terminology including ‘believes,’ ‘estimates,’ ‘anticipates,’ ‘expects,’ ‘plans,’ ‘projects,’ ‘intends,’ ‘potential,’ ‘may,’ ‘could,’ ‘might,’ ‘will,’ ‘should,’ ‘approximately’ or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in our most recently filed Form 10-K filed with the Securities and Exchange Commission (SEC) and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Investor Contact:
JTC Team, LLC
Jenene Thomas
(908) 824-0775
MBRX@jtcir.com

Planned integration intends to enable eligible ROLR customers to access ProphetX’s sports-focused exchange, supporting broader market choice and additional revenue opportunities

LAS VEGAS, Nevada, Nov. 12, 2026 (GLOBE NEWSWIRE) — High Roller Technologies, Inc. (“High Roller” or the “Company”) (NYSE: ROLR), an online gaming and prediction markets company, today announced that its wholly owned subsidiary, ROLR FCM LLC, has entered into a definitive commercial agreement with ProphetX LLC (“ProphetX”) to integrate access to ProphetX’s federally regulated prediction markets exchange through a ROLR-branded interface.

“Expanding the markets available through ROLR is an important part of building a platform that traders choose to engage with,” said Seth Young, Chief Executive Officer of High Roller. “Our agreement with ProphetX combines additional sports markets with a revenue-sharing structure that allows ROLR to earn a portion of net fees generated by traders accessing ProphetX’s exchange through our interface. We believe this creates an attractive opportunity to generate an additional revenue stream by building on the ROLR brand, customer experience and marketing capabilities as we grow the business.”

“ROLR is building a prediction markets business around its brand, customer experience and distribution capabilities,” said Jake Benzaquen, Co-Founder and Chief Commercial Officer of ProphetX. “Our infrastructure gives partners a way to bring our event contracts directly into their products, while ProphetX handles the exchange and clearing functions. We look forward to working with High Roller to extend access to our markets through ROLR.”

Agreement and Integration Highlights

• Expanded sports markets: The planned integration is intended to give eligible ROLR customers access to additional sports event contracts on ProphetX, whose markets cover outcomes such as game results, player performance and season-long championships. Participants trade with one another at prices determined by buying and selling activity.
• ROLR-branded experience: Eligible users would be able to view ProphetX market data, submit orders electronically for execution on ProphetX’s exchange, and access and manage their ProphetX trading accounts through a ROLR-branded interface.
• Regulated exchange infrastructure: ProphetX is registered with the Commodity Futures Trading Commission (the “CFTC”) as both a designated contract market and a derivatives clearing organization, providing the infrastructure for trading, clearing and settlement.
• Defined operating responsibilities: ROLR would manage branding, marketing, customer acquisition and interface distribution. ProphetX would maintain customer trading accounts and funds and handle onboarding, identity verification, trade execution, clearing, settlement and market surveillance. Trading would remain subject to ProphetX’s rules and eligibility requirements.
• Revenue participation: ROLR would receive a share of net fees generated by users accessing ProphetX through the ROLR-branded interface, creating an additional potential revenue source.
• Nonexclusive relationship: The agreement provides flexibility for ROLR to continue expanding its offering through connections to other exchanges, subject to the agreement’s terms.
• Timing and availability: The agreement provides for an effective date six months after ROLR FCM LLC receives registration as a futures commission merchant, unless the parties mutually agree otherwise. ROLR FCM LLC has not yet received such registration, and there can be no assurance as to whether or when it will be obtained. Commercial availability will depend on completion of the integration, operational readiness and satisfaction of applicable regulatory requirements. A launch date has not been announced.

Important Information

ROLR FCM LLC is not currently registered as a futures commission merchant with the CFTC or a member of the National Futures Association, and the integration described in this press release will not be made available unless and until all applicable registrations, approvals and conditions have been obtained or satisfied. Access to event contracts will be subject to ProphetX’s rules and eligibility requirements and to applicable law, and may not be available to all persons or in all jurisdictions. Trading event contracts involves substantial risk, including the risk of loss of the entire amount committed to a position, and is not suitable for all participants

About High Roller Technologies, Inc.

High Roller Technologies, Inc. (NYSE: ROLR) is a publicly traded online gaming and prediction markets company, known for its innovative casino brands High Roller and Fruta, and its prediction markets brand, ROLR. The Company delivers cutting-edge real-money consumer facing products that are intuitive and user-friendly. With a diverse portfolio of over 6,000 premium online casino games from more than 90 leading game providers, High Roller Technologies offers an immersive and engaging gaming experience in the rapidly expanding multi-billion-dollar iGaming industry. As an award-winning operator, High Roller Technologies continues to redefine the future of market engagement through innovation, performance, and a commitment to excellence.

For more information, please visit the Company’s investor relations website and follow High Roller Technologies on X, Facebook, and LinkedIn.

About ProphetX

Founded in 2018, ProphetX operates a U.S. prediction markets exchange and clearing organization registered with the CFTC. Built on a sports-focused foundation, its marketplace enables participants to trade event-based contracts at prices determined by market participants. ProphetX also provides infrastructure that enables other consumer platforms to integrate access to its markets. Its capabilities include a request-for-quote mechanism for pricing multi-event combinations. For more information, visit http://www.prophetx.co/partners.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, the commercial launch and growth of the ROLR^™ prediction markets platform, the anticipated integration with ProphetX, the expected effective date and terms of the agreement with ProphetX, the anticipated receipt of futures commission merchant registration by ROLR FCM LLC. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, our limited operating history in the prediction markets business; the ability of ROLR FCM LLC to obtain and maintain registration as a futures commission merchant and membership in the National Futures Association, and the timing thereof; the ability of the parties to complete the integration with ProphetX on the anticipated timeline or at all, and the risk that the agreement with ProphetX is terminated, modified or does not produce the anticipated revenue or other benefits; the nonexclusive nature of the agreement with ProphetX and competition from other platforms and exchanges; risks related to platform stability, scalability and technical performance, our ability to attract, convert and retain platform users and to generate revenue from the platform in the anticipated timeline or at all, the effectiveness of and cost of our marketing and customer-acquisition efforts and the performance of our marketing and distribution partners; our reliance on third parties, including Crypto.com | Derivatives North America, Crypto.com FCM and mrkts.com, and the continuation of our guarantee, license and development agreements; our ability to maintain the registration of ROLR US LLC as a guaranteed introducing broker and its membership in the National Futures Association, the evolving regulatory environment applicable to prediction markets and event-based contracts, and general market and economic conditions and such factors as discussed throughout Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2025, Part I. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors, of our quarterly report on Form 10-Q/A for the quarter ended June 30, 2026 and in our other filings with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contacts:

High Roller Investor Relations
ir@highroller.com
800-460-1039

ProphetX
Jake Benzaquen
Co-Founder & CCO
jake@prophetexchange.com
http://www.prophetx.co/partners

COLOMBO, Sri Lanka, Nov. 12, 2026 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Advanced Air Mobility (“AAM”) technology platform company, announced that its EH216-S pilotless electric vertical take-off and landing (“eVTOL”) aircraft completed Sri Lanka’s first human-carrying eVTOL flights in Colombo on November 11, which also marked the first such flights by Ehang pilotless eVTOL in South Asia. This milestone in the country’s advanced air mobility development advances EHang’s Global Fast Track Program in Sri Lanka from initial regulatory framework alignment to practical flight validation, laying the groundwork for future authorized commercial AAM operations.

(Photo: EH216-S conducts Sri Lanka’s first human-carrying eVTOL flight in Colombo)

The inaugural flight ceremony took place in Colombo, attended by senior government and aviation officials of Sri Lanka, led by Hon. Anura Karunathilaka, Minister of Ports and Civil Aviation of Sri Lanka; Hon. Janitha Ruwan Kodithuwakku, Deputy Minister of Ports and Civil Aviation; Capt. Daminda Rambukwella, Director General of Civil Aviation and Chief Executive Officer of the Civil Aviation Authority of Sri Lanka (“CAASL”); and Mr. Tang Yandi, Economic and Commercial Counsellor of the Embassy of the People’s Republic of China in Sri Lanka, alongside EHang executives including Conor Yang, Chief Financial Officer of EHang, and Xiaona Lee, China General Manager of EHang, as well as representatives from relevant government agencies, business partners, and members of the media.

Minister Karunathilaka and Deputy Minister Kodithuwakku were among the first guests to fly aboard the EH216-S, followed by W. W. S. Mangala, Secretary of the Ministry of Ports and Civil Aviation. The flights followed a scenic loop route along the coastline, giving guests a first-hand experience of the aircraft’s pilotless, safe and smooth operation. Commemorative flight tickets were also presented to mark this milestone in Sri Lanka’s AAM development.

 (Photo: Minister Karunathilaka and Deputy Minister Kodithuwakku experience a flight aboard EH216-S)

To date, EHang’s EH216 series eVTOL aircraft have completed nearly 100,000 safe flights, with Sri Lanka becoming the 24th country to join this growing global flight footprint.

(Photo: EH216-S conducts Sri Lanka’s first human-carrying eVTOL flight in Colombo)

Sri Lanka became the first country to adopt EHang’s Global Fast Track Program in August 2026. With the inaugural flights, the program has entered its flight validation phase. Going forward, EHang and its local partners will work with local regulators to conduct flight testing and operational validation, assessing aircraft performance and safety, generating operational data to inform regulatory reviews and subsequent approvals, and paving the way for future commercial operations.

(Photo: EH216-S conducts Sri Lanka’s first human-carrying eVTOL flight in Colombo)

Hon. Anura Karunathilaka, Minister of Ports and Civil Aviation of Sri Lanka, commented, “Having experienced the EH216-S firsthand, I was impressed by EHang’s technology and its progress in developing and operating autonomous eVTOL aircraft. We believe this technology has the potential to transform the future of aviation in our country, creating new opportunities in tourism, air taxi services, search and rescue operations and other applications. I congratulate EHang and all the partners and stakeholders whose cooperation has made this milestone possible. The Government remains committed to exploring the potential of this emerging technology for Sri Lanka.”

(Photo: Hon. Anura Karunathilaka, Minister of Ports and Civil Aviation of Sri Lanka delivers a speech at the event)

Capt. Daminda Rambukwella, Director General of Civil Aviation and Chief Executive Officer of CAASL, commented, “The event marks a historic milestone for Sri Lanka and an important moment for aviation in South Asia, as we introduce pilotless, human-carrying eVTOL technology to the country for the first time. This is an emerging technology that calls for new approaches to regulation and oversight as the global aviation industry continues to evolve. Through this program, we aim to build the necessary experience and frameworks to support its safe development and future operations.”

(Photo: Capt. Daminda Rambukwella, Director General of Civil Aviation and Chief Executive Officer of CAASL delivers a speech at the event)

Mr. Tang Yandi, Counsellor of the Embassy of the People’s Republic of China in Sri Lanka, commented, “As a leading Chinese company in the low-altitude economy, EHang is bringing the EH216-S pilotless human-carrying eVTOL aircraft to Sri Lanka, opening a new chapter in China-Sri Lanka cooperation in AAM. We extend warm congratulations on the launch of this project. Sri Lanka, with its beautiful landscape and distinctive island character, holds great promise for the low-altitude economy. Aerial sightseeing can add a new highlight to local tourism. Pilotless aerial vehicles can also play a valuable role in emergency rescue and the delivery of disaster-relief supplies, while offering flexible transport solutions for hard-to-reach areas such as islands and mountainous regions. We look forward to seeing the company continue to put safety first and uphold rigorous quality standards, so that the fruits of innovation better benefit the people of Sri Lanka.” 

(Photo: Mr. Tang Yandi, Counsellor of the Embassy of the People’s Republic of China in Sri Lanka)

Conor Yang, Chief Financial Officer of EHang, stated, “EHang’s Global Fast Track Program is a key pillar of our international market entry strategy, designed to bring not only our innovative pilotless eVTOL aircraft but also the broader ecosystem and operational capabilities needed to establish AAM services in local markets. It was a great honor to welcome the Minister, the Deputy Minister and the Secretary of the Ministry of Ports and Civil Aviation aboard the EH216-S, and we are grateful for their confidence in taking this first flight with us. Working closely with CAASL and our local partners, we are turning this approach into concrete progress on the ground, demonstrating our ability to build and deploy an integrated AAM ecosystem in international markets.”

Watch the video of the inaugural flight ceremony: https://www.ehang.com/video/show/664.html

About EHang

EHang (Nasdaq: EH) is the world’s leading Advanced Air Mobility technology platform company dedicated to making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang focuses on the research, development and manufacturing of a diversified portfolio of pilotless electric vertical take-off and landing (eVTOL) aerial vehicles, covering a wide range of application scenarios including aerial tourism, intra-city commuting, inter-city travel, logistics transportation and emergency firefighting. EHang’s flagship product, the EH216-S, has obtained the world’s first type certificate (TC), production certificate (PC) and standard airworthiness certificate (AC) for pilotless passenger-carrying eVTOL aircraft issued by the Civil Aviation Administration of China (CAAC), and has entered operation under China’s first batch of Air Operator Certificates (OC) for pilotless passenger-carrying eVTOL aircraft. In addition, the Company’s long-range VT35 model further extends inter-city mobility scenarios, laying the foundation for a multi-tiered low-altitude mobility network. Leveraging its advanced autonomous flight technology and scalable operational infrastructure, EHang is redefining the transportation of people and goods — transcending cities, regions and natural barriers to usher in a new era of air mobility. For more information, please visit www.ehang.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “may” and other similar expressions. Statements that are not historical facts, including statements regarding management’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Many factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to product certification, the Company’s expectations regarding demand for and market acceptance of its products, the commercialization of the Company’s unmanned aerial vehicle products and solutions and Advanced Air Mobility services, its relationships with strategic partners, its international deployment plans, regulatory sandbox initiatives, aircraft deployment, local operational approvals, the timing of flight validation and commercial operations in overseas markets, and the litigation currently involving the Company and potential litigation. The Company’s management has made such forward-looking statements based on current expectations, assumptions, estimates and projections. While the Company’s management believes that these expectations, assumptions, estimates and projections are reasonable, forward-looking statements are only predictions of future events and involve known and unknown risks and uncertainties that are difficult for the Company’s management to control. These risks and uncertainties may cause EHang’s actual results of operations, performance or achievements to differ materially from those expressed or implied by any forward-looking statements.

Media Contact: pr@ehang.com

Investor Contact: ir@ehang.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/24fc67cc-e765-44a8-a2ae-43792e78895a

https://www.globenewswire.com/NewsRoom/AttachmentNg/592b8479-b25c-4de7-8039-42c5bf6ce79a

https://www.globenewswire.com/NewsRoom/AttachmentNg/8f9cf833-1ba1-41ca-a0cc-f642a01430df

https://www.globenewswire.com/NewsRoom/AttachmentNg/37d1be40-8b4e-40a1-97b0-6b985facd6a6

https://www.globenewswire.com/NewsRoom/AttachmentNg/70610a61-2a15-47aa-8939-a3c79f84bb76 

https://www.globenewswire.com/NewsRoom/AttachmentNg/66f4736e-d979-49b6-a515-b260888e1a05

https://www.globenewswire.com/NewsRoom/AttachmentNg/bd442863-5f68-4160-b292-acc6c1bcb275

https://www.globenewswire.com/NewsRoom/AttachmentNg/6c71ce0d-dc01-4e8a-a91f-e55b20828c9b

Phunware Brings MyChart Pre-Login Landing Page and Blue-Dot Indoor Wayfinding to Epic Customers

AUSTIN, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a mobile-first enterprise patient intelligence platform company, today announced that Phunware Interactive Maps and Wayfinding is now available in the Wayfinding category of Toolbox on Epic Showroom, Epic’s marketplace where anyone can discover products that can connect to Epic. Phunware Patient Digital Front Door is also live in Epic Showroom as a Connection Hub listing.

Large health system campuses can span multiple buildings, parking structures and entrances, and patients and caregivers often arrive anxious, unwell or unfamiliar with the facility, resulting in arriving late or missing appointments that are costly to the health system. Phunware’s technology addresses this common issue. Patients of customers which have partnered with Epic can now receive a landing page in MyChart with directions, parking and visitor information before they sign in, and precise turn-by-turn indoor directions once they arrive on site.

Through Epic Showroom, Phunware offers two healthcare solutions for new and existing healthcare customers:

• Phunware Patient Digital Front Door (Connection Hub listing). Provides patients, caregivers and visitors with easy access to critical patient resources such as locations, directions, parking, visitor information, scheduling and bill pay from the MyChart login screen before they sign in, in a branded experience each health system configures. Patients know where to go and how to get there before they ever arrive.
• Phunware Interactive Maps and Wayfinding (Toolbox, Wayfinding category). Helps patients, staff, vendors, caregivers, and visitors navigate complex, multi-building health system campuses turn by turn, with precise indoor positioning and real-time updates to reach the right entrance, department, area and room without stopping to ask for directions.

“Navigation failure in a hospital or health system campus is not an inconvenience. It is a missed or late appointment or procedure and generates significant costs which the administration has to absorb,” said Dmitry Kroshka, Chief Executive Officer of Phunware. “Availability in Toolbox on Epic Showroom puts our healthcare location-aware platform in front of the health systems that partner with Epic. By pairing a MyChart entry point with precise indoor wayfinding we can help hospitals and other health system campuses guide patients, doctors, nurses, other staff and visitors from the parking lot directly to the procedure room and through recovery. This is only the first step. As a next step and part of Phunware 2.0, we are building a location-aware intelligence layer around the appointment itself, so hospitals and other health systems can see who is at risk of arriving late or missing an appointment and act before it happens.”

The announcement marks another step in Phunware’s evolving technology offerings leading to Phunware 2.0, which is envisioned to bring together mobile, location-aware and AI capabilities that typically operate in separate silos into a shared intelligence platform supporting applications in hospitality, healthcare and other verticals involving complex physical environments. Epic’s reach among health systems lets Phunware reach many health systems in the Epic environment they already use, and Phunware’s platform is available to health systems that do not use Epic as well. Health systems interested in Phunware’s Epic-connected capabilities can learn more at phunware.com/industry/healthcare.

About Phunware

Phunware, Inc. (NASDAQ: PHUN) is an enterprise software company specializing in mobile app solutions for hospitality, healthcare, and other large property related customers, with integrated intelligent capabilities. We provide businesses with the tools to create, implement, and manage custom mobile applications, analytics, and location-based services. Phunware is transforming mobile engagement by delivering scalable, personalized, and data-driven mobile app experiences.

Phunware’s mission is to achieve unparalleled connectivity and monetization through the widespread adoption of Phunware mobile technologies, leveraging brands, consumers, partners, and market participants. Phunware is poised to expand its software products and services audience through new generative AI products and product enhancements which are in development, utilize and monetize its patents and other intellectual property, and focus on serving its enterprise customers and partners.

For more information on Phunware, please visit www.phunware.com.

Safe Harbor / Forward-Looking Statements

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our business strategy and plans, our objectives for future operations, the development and delivery of the Phunware Interactive Maps and Wayfinding and Phunware Patient Digital Front Door for Epic customers and our healthcare customers, the development and commercial rollout of our Product 2.0 strategy, and the expansion of our product offering into healthcare and other adjacent end markets, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” and similar expressions are intended to identify forward-looking statements.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. These forward-looking statements involve risks, uncertainties, and other assumptions that may cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in our filings with the SEC. We undertake no obligation to update any forward-looking statements.

By their nature, forward-looking statements involve risks and uncertainties. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those expressed or implied by these forward-looking statements.

Epic, MyChart and Showroom are trademarks of Epic Systems Corporation.

Media Contact:
Scott Berwitz, Greenpoint Agency
scott@greenpoint.agency

Investor Relations Contact:
Chris Tyson, Executive Vice President
MZ Group – MZ North America
949-491-8235
PHUN@mzgroup.us
www.mzgroup.us

– Call to Follow Presentation of New Data at Upcoming Society for Neuro-Oncology SNO Conference –

JERUSALEM, Nov. 12, 2026 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq/TASE: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that it will host a conference call and webcast on Monday, Nov. 16, 2026, at 8:30 a.m. ET to discuss new interim results from REGAIN (Recurrent Glioblastoma Alpha DaRT Intratumoral Therapy), its U.S. multicenter trial exploring the use of Alpha DaRT in patients with recurrent glioblastoma. The call will take place on the back of the presentation of the results at the 31^st Annual Meeting of the Society for Neuro-Oncology (SNO), to be held Nov. 12-15, 2026, in Philadelphia.

The call will feature REGAIN principal investigator Dr. Joshua Palmer of The Ohio State University; Uzi Sofer, CEO of Alpha Tau; Robert Den, MD, Chief Medical Officer of Alpha Tau; and Raphi Levy, CFO of Alpha Tau.

Conference Call and Webcast Details

• Date: Monday, Nov. 16, 2026
• Time: 8:30 a.m. ET
• Web Access: https://alpha-dart-rgbm-at-sno-26.open-exchange.net/

An archived webcast will be available on the Company’s website following the event.

About the REGAIN Study

The clinical trial is expected to enroll up to 20 U.S. patients with recurrent glioblastoma not amenable to surgical resection who have undergone a prior course of central nervous system radiation. The primary objective of the study is to evaluate the feasibility and safety of the treatment, following the Company’s promising results from pre-clinical studies. Additional information about the trial can be found at https://www.clinicaltrials.gov/study/NCT06910306

About Alpha Tau Medical Ltd.

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company focused on the research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

About Alpha DaRT^®

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to primarily affect the tumor and to spare healthy tissue surrounding it. For intracranial use, Alpha DaRT sources are delivered via a specialized stereotactic delivery system that interfaces with standard real-time neuronavigation platforms, with the goal of precise, image-guided source placement through minimally invasive burr-hole access without requiring open craniotomy.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. When used herein, words including “anticipate,” “will,” “plan,” “may,” “continue,” and similar expressions are intended to identify forward-looking statements. Other than its marketing approval in Japan for unresectable locally advanced or locally recurrent head and neck cancer and in Israel for products intended to treat Squamous Cell Carcinoma (SCC) of the Skin and Oral Cavity, the Alpha DaRT treatment has not been approved for commercialization or for use outside of an approved clinical trial. In addition, any statements or information that refer to the Alpha DaRT treatment in glioblastoma patients, including the timing and content of the conference call and webcast and of the presentation at the SNO Annual Meeting, the expected enrollment and conduct of the REGAIN trial, the potential benefits and associated risks, safety, feasibility and efficacy, future applications and uses, and other expectations, beliefs and plans, including with respect to clinical trials, regulatory approvals and studies, are forward-looking. All forward-looking statements are based upon Alpha Tau’s current expectations and various assumptions. Alpha Tau believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Alpha Tau may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation: (i) Alpha Tau’s ability to receive regulatory approval for its Alpha DaRT technology or any future products or product candidates; (ii) Alpha Tau’s limited operating history; (iii) Alpha Tau’s incurrence of significant losses to date; (iv) Alpha Tau’s need for additional funding and ability to raise capital when needed; (v) Alpha Tau’s limited experience in medical device discovery and development; (vi) Alpha Tau’s dependence on the success and commercialization of the Alpha DaRT technology; (vii) the failure of preliminary data from Alpha Tau’s clinical studies to predict final study results; (viii) failure of Alpha Tau’s early clinical studies or preclinical studies to predict future clinical studies; (ix) Alpha Tau’s ability to enroll patients in its clinical trials; (x) undesirable side effects caused by Alpha Tau’s Alpha DaRT technology or any future products or product candidates; (xi) Alpha Tau’s exposure to patent infringement lawsuits; (xii) Alpha Tau’s ability to comply with the extensive regulations applicable to it; (xiii) the ability to meet Nasdaq’s listing standards; (xiv) costs related to being a public company; (xv) changes in applicable laws or regulations; and the other important factors discussed under the caption “Risk Factors” in Alpha Tau’s annual report filed on Form 20-F with the SEC on March 9, 2026, and other filings that Alpha Tau may make with the United States Securities and Exchange Commission. These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While Alpha Tau may elect to update such forward-looking statements at some point in the future, except as required by law, it disclaims any obligation to do so, even if subsequent events cause its views to change. These forward-looking statements should not be relied upon as representing Alpha Tau’s views as of any date subsequent to the date of this press release.

Investor Relations Contact:
IR@alphatau.com

GAAP diluted EPS increased 50% to $0.15 as net income reached $7.6 million

Gross profit increased 13% to $42.1 million; gross margin expanded to 15.1%

Physical movie revenue increased 20%; vinyl revenue rose 14% and CD revenue grew 22%

Collectibles revenue increased 87%

PLANTATION, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, today reported its financial and operational results for the first quarter of fiscal 2027, ended September 30, 2026.

First Quarter Fiscal 2027 Financial Highlights

• Net Revenues: Increased 10% to $278.8 million, compared with $254.0 million in the first quarter of fiscal 2026.
• Gross Profit and Margin: Gross profit increased 13% to $42.1 million from $37.2 million, while gross margin expanded 50 basis points to 15.1% from 14.6%.
• GAAP Net Income and EPS: Net income increased 56% to $7.6 million, compared with $4.9 million in the prior-year quarter. GAAP diluted earnings per share increased 50% to $0.15 from $0.10.
• Operating Income: Operating income was $10.6 million, compared with $10.5 million in the prior-year quarter.
• Adjusted EBITDA: Increased approximately 1% to $12.3 million, compared with $12.2 million in the prior-year quarter.
• Adjusted Net Income and Adjusted Diluted EPS: Adjusted net income was $7.2 million, compared with $7.3 million in the prior-year quarter, while adjusted diluted earnings per share remained unchanged at $0.14.
• Interest Expense: Decreased 49% to $1.2 million from $2.3 million, reflecting lower borrowing costs following the Company’s October 2025 refinancing.
• Operating Cash Flow: Net cash provided by operating activities increased 58% to $4.3 million, compared with $2.7 million in the prior-year quarter.
• Liquidity: The Company ended the quarter with approximately $48.9 million of availability under its $120 million revolving credit facility, along with $33.4 million of additional collateral-supported borrowing capacity above the facility’s current commitment limit. This excess collateral capacity could support a future expansion of the credit facility, subject to applicable conditions and lender approval.

“Fiscal 2027 is off to a strong start, with 10% revenue growth, higher gross margins and significant improvement in GAAP net income and earnings per share,” said Jeff Walker, Chief Executive Officer of Alliance Entertainment. “Physical music, movies and collectibles all grew, with collectibles revenue up 87%. For a long time, so much of the conversation was about streaming replacing physical formats. But what we’ve seen consistently is that fans who can listen to an album or watch a movie online still want something special they can own and collect. The entertainment industry is increasingly recognizing the value of these highly engaged consumers—the superfans—and the growing demand for physical products that we’ve been seeing for years.”

“We believe everybody is a superfan of something, and those fans want products that bring them closer to what they love,” Walker continued. “And when you offer a limited edition or an exclusive collectible, that adds another dimension, because now they have a unique product not everybody else has. This is right in our wheelhouse. We have the studio and label relationships, the retail reach and the fulfillment capabilities to get these products into fans’ hands. What’s exciting is that as more content owners look for ways to serve these fans, they need partners who understand both the products and how to bring them to market. That creates a lot of opportunity for Alliance.”

“First-quarter results reflect continued revenue growth and gross margin improvement, along with the benefits of our strengthened financing structure,” said Amanda Gnecco, Chief Financial Officer of Alliance Entertainment. “Gross profit increased approximately 13%, outpacing revenue growth, while interest expense declined nearly 49% following our refinancing with Bank of America. GAAP net income increased 56% to $7.6 million, benefiting from lower borrowing costs and a favorable non-cash change in the fair value of warrant liabilities.”

“We also made progress on our objective of improving cash generation,” Gnecco added. “Operating cash flow increased to $4.3 million from $2.7 million a year ago, despite continued investment in inventory to support customer demand and anticipated sales activity as we enter the holiday season. As we move through fiscal 2027, our priorities remain focused on profitable growth, working-capital efficiency, expense discipline and improving operating leverage. With lower borrowing costs and substantial availability under our revolving credit facility, we believe we have the financial flexibility to support our strategic initiatives while continuing to strengthen the business.”

Strategic & Operating Highlights

• Physical Movie Growth Supported by Major Studio Relationships: Physical movie revenue increased 20% to $101.1 million, compared with $84.0 million in the prior-year quarter. Growth benefited from new releases and expanded retail availability through the Company’s exclusive physical-media distribution relationships with Paramount and Amazon MGM Studios.
• Vinyl and CDs Delivered Double-Digit Growth: Vinyl revenue increased 14% to $86.7 million from $75.8 million, while CD revenue increased 22% to $41.2 million from $33.9 million. New releases, reissues and collectible editions supported physical music demand, with both formats benefiting from higher unit sales and average selling prices.
• Collectibles Revenue Increased 87%: Collectibles revenue increased to $11.9 million from $6.4 million, supported by expanded licensed merchandise offerings, broader sourcing initiatives and vendor relationships, and the Company’s owned Handmade by Robots™ brand. Collectibles represented 4.3% of quarterly revenue, compared with 2.5% in the prior-year period.
• Distribution and Fulfillment Revenue Increased 18%: Distribution and fulfillment fee revenue increased to $5.7 million from $4.8 million, reflecting higher demand for the Company’s distribution, fulfillment and value-added logistics services.
• Authentication and Digital Product Identity Development Continued: Alliance continued developing NFC-enabled authentication and digital product identity capabilities through Endstate Authentic and Alliance Authentic™. These initiatives are designed to support product verification, provenance, preservation and authenticated resale across premium physical entertainment and collectibles.
• Technology and Automation Initiatives Focused on Productivity: Alliance continued investing in warehouse automation and expanding its use of artificial intelligence to streamline workflows and improve financial and operational processes. These efforts are intended to reduce manual work and support more efficient operations as the business grows.

First Quarter Fiscal 2027 Financial Review

Net revenues for the first quarter of fiscal 2027 increased $24.9 million, or 10%, to $278.8 million from $254.0 million in the prior-year quarter. Revenue growth was driven primarily by higher sales of physical movies, vinyl records, CDs and collectibles, partially offset by declines in gaming and digital downloads.

Physical movie revenue increased $17.1 million, or 20%, to $101.1 million, supported by higher unit volumes and the Company’s expanding relationships with major studios. Vinyl revenue increased $10.9 million, or 14%, to $86.7 million, while CD revenue increased $7.3 million, or 22%, to $41.2 million. Collectibles revenue increased $5.5 million, or 87%, to $11.9 million, reflecting continued expansion in licensed merchandise and proprietary products. These increases were partially offset by an $18.4 million decline in gaming revenue, primarily reflecting lower product availability and the absence of certain prior-year sales associated with the Nintendo Switch 2 launch.

Gross profit increased $5.0 million, or approximately 13%, to $42.1 million from $37.2 million in the prior-year quarter. Gross margin improved 50 basis points to 15.1% from 14.6%, reflecting stronger product margins and favorable contributions from the Company’s evolving product mix.

Total operating expenses increased to $31.5 million from $26.6 million in the prior-year quarter, primarily reflecting higher selling, general and administrative expenses and distribution and fulfillment costs. Distribution and fulfillment expenses increased to $12.0 million from $9.9 million, driven primarily by higher warehouse payroll and operating costs associated with increased business activity, specialized product handling and fulfillment requirements. Selling, general and administrative expenses increased to $17.9 million from $15.1 million, reflecting higher employee-related expenses, professional-service costs and investments supporting the Company’s strategic initiatives.

Operating income was $10.6 million, compared with $10.5 million in the prior-year quarter. The increase in gross profit was substantially offset by higher operating expenses as the Company continued supporting revenue growth and investing in its operational capabilities.

Interest expense decreased $1.1 million, or 49%, to $1.2 million from $2.3 million in the prior-year quarter. The decrease primarily reflected a reduction in the Company’s average effective interest rate to 5.3% from 8.4% following the October 2025 refinancing of its revolving credit facility with Bank of America. Lower borrowing costs more than offset the impact of higher average borrowings during the quarter.

GAAP net income increased $2.7 million, or 56%, to $7.6 million from $4.9 million in the prior-year quarter. GAAP diluted earnings per share increased 50% to $0.15 from $0.10. The year-over-year improvement reflected lower interest expense and a favorable change in the fair value of warrant liabilities, partially offset by higher income tax expense. The Company recorded a non-cash gain of approximately $0.9 million related to warrant remeasurement during the quarter, compared with a non-cash loss of approximately $1.5 million in the prior-year period.

Adjusted EBITDA increased approximately 1% to $12.3 million from $12.2 million in the prior-year quarter. Adjusted net income was $7.2 million, while adjusted diluted earnings per share remained unchanged at $0.14. These non-GAAP measures exclude certain items that management does not consider representative of ongoing operating performance, including non-cash warrant remeasurement adjustments.

Net cash provided by operating activities increased to $4.3 million from $2.7 million in the prior-year quarter. Operating cash flow benefited from the Company’s higher earnings and changes in working capital, including increased accounts payable, partially offset by higher inventory and receivables. Inventory increased to $152.0 million at September 30, 2026, from $126.6 million at June 30, 2026, reflecting investment to support sales growth and anticipated customer demand.

At September 30, 2026, the Company had approximately $70.8 million outstanding under its $120 million revolving credit facility, with approximately $49.2 million of availability. The Company remained in compliance with applicable credit facility covenants. Management continues to prioritize working-capital efficiency, inventory productivity, receivable collections and disciplined capital allocation while supporting growth across physical entertainment, collectibles, fulfillment and authentication technologies.

Conference Call

Alliance Entertainment Chief Executive Officer Jeff Walker, Chief Financial Officer Amanda Gnecco, and Executive Chairman Bruce Ogilvie will host the conference call, which will be followed by a question-and-answer session. A presentation will accompany the call and can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.

To access the call, please use the following information:

Date:	Thursday, November 12, 2026
Time:	4:30 p.m. Eastern Time, 1:30 p.m. Pacific Time
Toll-free dial-in number:	1-844-825-9789
International dial-in number:	1-412-317-5180
Conference ID:	10213070

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact RedChip Companies at 1-407-644-4256.

The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1781348&tp_key=9221210ff0 and via the investor relations section of the Company’s website here.

A telephone replay of the call will be available approximately three hours after the call concludes and can be accessed through December 12, 2026, using the following information:

Toll-free replay number:	1-844-512-2921
International replay number:	1-412-317-6671
Replay ID:	10213070

About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 340,000 unique in-stock SKUs – including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games – Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. Alliance also owns and operates proprietary collectibles brands, including Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises, and Alliance Authentic™, a premium platform for authentic, certified, and individually numbered entertainment collectibles. In addition, Alliance operates Endstate Authentic, a dedicated NFC-enabled authentication and digital product identity platform supporting authenticated collectibles, resale, and brand protection. Leveraging decades of operational expertise, exclusive sourcing relationships, and a capital-light, scalable infrastructure, Alliance connects fans and collectors to the products, franchises, and experiences they value across formats and generations. For more information, visit www.aent.com.

Forward Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; risks that a breach of the revolving credit facility could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, uncertainty regarding tariffs, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

For investor inquiries, please contact:

Dave Gentry
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
AENT@redchip.com

ALLIANCE ENTERTAINMENT HOLDING CORP.
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
		Three Months Ended				Three Months Ended
($ in thousands except share and per share amounts)		September 30, 2026				September 30, 2025
Net Revenues		$	278,830			$	253,974
Cost of Revenues (excluding depreciation and amortization)			236,699				216,793
Operating Expenses
Distribution and Fulfillment Expense			12,025				9,920
Selling, General and Administrative Expense			17,944				15,078
Depreciation and Amortization			1,426				1,286
Transaction Costs			112				370
Gain on Disposal of Fixed Assets			–				(20	)
Total Operating Expenses			31,507				26,634
Operating Income			10,624				10,547
Other Expenses
Interest Expense			1,201				2,347
State tax benefit from prior year			(3	)			–
Change in Fair Value of Warrants			(850	)			1,462
Total Other Expenses			348				3,809
Income Before Income Tax Expense			10,276				6,738
Income Tax Expense			2,655				1,858
Net Income		$	7,621			$	4,880
Other Comprehensive Income
Foreign Currency Translation			–				–
Total Comprehensive Income		$	7,621			$	4,880
Net Income per Share – Basic and Diluted		$	0.15			$	0.10
Weighted Average Common Shares Outstanding – Basic			50,979,630				50,957,370
Weighted Average Common Shares Outstanding – Diluted			51,082,171				50,996,141

ALLIANCE ENTERTAINMENT HOLDING CORP.
UNAUDITED CONSOLIDATED BALANCE SHEETS
($ in thousands except per share amounts)		September 30, 2026				June 30, 2026
			(Unaudited)
Assets
Current Assets
Cash		$	649			$	814
Trade Receivables, Net of Allowance for Credit Losses of $1,011 and $811, respectively			119,547				111,038
Inventory, Net			152,019				126,599
Other Current Assets			8,857				9,843
Total Current Assets			281,072				248,294
Property and Equipment, Net			10,301				10,564
Operating Lease Right-of-Use Assets, Net			15,292				16,062
Goodwill			94,081				94,081
Intangibles, Net			17,499				18,457
Other Long-Term Assets			9,630				9,932
Deferred Tax Asset, Net			210				210
Total Assets		$	428,085			$	397,600
Liabilities and Stockholders’ Equity
Current Liabilities
Accounts Payable		$	198,769			$	170,958
Accrued Expenses			9,101				8,361
Current Portion of Operating Lease Obligations			3,406				3,329
Current Portion of Finance Lease Obligations			1,133				1,937
Deferred Consideration			1,300				1,300
Total Current Liabilities			213,709				185,885
Revolving Credit Facility, Net			70,311				73,721
Operating Lease Obligations, Non-Current			13,368				14,217
Contingent Liability, Non-Current			5,500				5,500
Acquired Royalty Obligation (Endstate), Non-Current			165				165
Warrant Liability			588				1,496
Total Liabilities			303,641				280,984
Commitments and Contingencies (Note 13)
Stockholders’ Equity
Preferred Stock: Par Value $0.0001 per share, Authorized 1,000,000 shares, Issued and Outstanding and shares as of September 30, 2026, and June 30, 2026			–				–
Common Stock: Par Value $0.0001 per share, Authorized 550,000,000 shares at September 30, 2026, and at June 30, 2026; Issued and Outstanding 50,979,630 Shares as of September 30, 2026, and June 30, 2026, respectively			5				5
Paid In Capital			49,114				48,907
Accumulated Other Comprehensive Loss			(77	)			(77	)
Retained Earnings			75,402				67,781
Total Stockholders’ Equity			124,444				116,616
Total Liabilities and Stockholders’ Equity		$	428,085			$	397,600

ALLIANCE ENTERTAINMENT HOLDING CORP.
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
		Three Months Ended				Three Months Ended
($ in thousands)		September 30, 2026				September 30, 2025
Cash Flows from Operating Activities:
Net Income		$	7,621			$	4,880
Adjustments to Reconcile Net Income to
Net Cash Provided by Operating Activities:
Depreciation of Property and Equipment			468				442
Amortization of Intangible Assets			958				844
Amortization of Deferred Financing Costs (Included in Interest Expense)			32				351
Allowance for Credit Losses			344				79
Change in Fair Value of Warrants			(850	)			1,462
Non-cash lease expense			770				779
Stock-based Compensation Expense			149				25
Gain on Disposal of Fixed Assets			–				(20	)
Changes in Assets and Liabilities
Trade Receivables			(8,853	)			758
Inventory			(25,420	)			(18,880	)
Income Taxes PayableReceivable			2,410				1,516
Operating Lease Obligations			(772	)			(742	)
Other Assets			1,001				(3,459	)
Accounts Payable			27,811				18,545
Accrued Expenses and Contingent Liability			(1,382	)			(3,860	)
Net Cash Provided By Operating Activities			4,287			$	2,720
Cash Flows from Investing Activities:
Capital Expenditures			(205	)			(345	)
Cash Inflow from Asset Disposal			–				26
Net Cash Used in Investing Activities			(205	)			(319	)
Cash Flows from Financing Activities:
Payments on Financing Leases			(804	)			(746	)
Payments on Revolving Credit Facility			(256,609	)			(234,317	)
Borrowings on Revolving Credit Facility			253,166				234,699
Deferred Financing Costs			–				(50	)
Net Cash Used In Financing Activities			(4,247	)			(414	)
Net Increase/(Decrease) Increase in Cash			(165	)			1,987
Net Effect of Currency Translation on Cash			–				–
Cash, Beginning of the Period			814				1,236
Cash, End of the Period		$	649			$	3,223
Supplemental disclosure for Cash Flow Information
Cash Paid for Interest		$	1,105			$	2,313
Cash Paid for Income Taxes		$	245			$	342

Non-GAAP Financial Measures: EBITDA, Adjusted EBITDA, Adjusted Net Income, and Adjusted Earnings per Diluted Share (collectively, the “Non-GAAP Financial Measures”) are supplemental measures of our performance that are not required by, or presented in accordance with, U.S. GAAP. The Non-GAAP Financial Measures are not measurements of our financial performance under U.S. GAAP and should not be considered as alternatives to net income, earnings per share or any other performance measure derived in accordance with U.S. GAAP. We define EBITDA as net income before interest expense, net, income tax expense, depreciation and amortization. We define Adjusted EBITDA as EBITDA further adjusted for non-cash charges related to equity-based compensation programs, acquisition and deal-related costs, changes in the fair value of warrants, insurance claim recoveries, and restructuring costs and net gains and losses on the disposal of assets. We define Adjusted Net Income as net income adjusted for the impact of certain non-cash charges and other items that we do not consider in our evaluation of ongoing operating performance. These items include, among other things, non-cash charges related to equity-based compensation programs, acquisition and deal-related costs, amortization of acquisition-related intangible assets, amortization of deferred financing costs, changes in the fair value of warrants and litigation costs and settlements, regulatory assessments and insurance settlements, and the income tax expense effect of these adjustments. We define Adjusted Earnings per Diluted Share as Adjusted Net Income divided by the weighted-average shares outstanding used in the calculation of diluted earnings per share in accordance with U.S. GAAP.

We caution investors that amounts presented in accordance with our definitions of the Non-GAAP Financial Measures may not be comparable to similar measures disclosed by our competitors, because not all companies and analysts calculate the Non-GAAP Financial Measures in the same manner. We present the Non-GAAP Financial Measures because we consider them to be important supplemental measures of our performance and believe they are frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including these Non-GAAP Financial Measures as a reasonable basis for comparing our ongoing results of operations.

The following tables reconcile the Non-GAAP Financial Measures to the most directly comparable U.S. GAAP financial performance measure, which is net income, for the periods presented:

		Three Months Ended				Three Months Ended
(in thousands, except share and per share data)		September 30, 2026				September 30, 2025
Net income		$	7,621			$	4,880
Equity-based compensation (1)			149				25
Acquisition and deal-related costs (2)			112				370
Amortization of acquisition-related intangible assets (3)			105				90
Amortization of deferred financing costs (4)			32				351
Change in fair value of warrants and contingent consideration (5)			(850	)			1,462
Litigation costs and settlements (6)			237				382
State Tax benefit from prior year (10)			(3	)			–
Income tax effect of adjustments (7)			(158	)			(305	)
Adjusted net income		$	7,245			$	7,255
Weighted-average shares outstanding—basic			50,979,630				50,957,370
Effect of dilutive securities			102,541				38,771
Weighted-average shares outstanding—diluted			51,082,171				50,996,141
Earnings per diluted share		$	0.15			$	0.10
Adjusted earnings per diluted share		$	0.14			$	0.14

($ in thousands)		Three Months Ended September 30, 2026				Three Months Ended September 30, 2025
Net income		$	7,621			$	4,880
Add back:
Interest expense, net			1,201				2,347
Income tax expense			2,655				1,858
Depreciation and amortization (8)			1,426				1,286
EBITDA			12,903				10,371
Adjustments:
Acquisition and deal-related costs (2)			112				370
Equity-based compensation (1)			149				25
Change in fair value of warrants and contingent consideration (5)			(850	)			1,462
State tax benefit from Prior Year (10)			(3	)			–
Gain on disposal of property and equipment (9)			–				(20	)
Adjusted EBITDA		$	12,311			$	12,208

(1) Represents non-cash charges related to equity-based compensation programs, which vary from period to period depending on the timing of awards.
(2) Represents costs incurred in connection with completed and contemplated business combinations, including advisory, legal, accounting and other professional fees.
(3) Represents amortization of intangible assets acquired in business combinations. The revenue generated by those intangible assets is not excluded from the Non-GAAP Financial Measures.
(4) Represents amortization of debt issuance costs incurred in connection with our credit facility with Bank of America and the terminated White Oak Credit Facility.
(5) Represents non-cash gains and losses resulting from the remeasurement of warrant liabilities and contingent consideration to fair value at each reporting date.
(6) Represents legal fees, settlement amounts and other costs associated with litigation matters that we do not consider indicative of our ongoing operating performance.
(7) Represents the income tax effect of the above adjustments. This adjustment uses a blended federal and state statutory income tax rate of 25% for all periods presented and is applied only to those adjustments that carry an income tax consequence. Changes in the fair value of warrants and contingent consideration are not deductible for income tax purposes and accordingly have not been tax effected.
(8) Represents total depreciation and amortization determined in accordance with U.S. GAAP, which includes amortization of acquisition-related intangible assets. Accordingly, no separate adjustment for that amortization is presented in the reconciliation of EBITDA to Adjusted EBITDA.
(9) Represents net gains and losses on the disposal of property and equipment.
(10) State Tax refund for abandoned property

• Pivotal Phase 3 trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome reached last patient last visit in September 2026, with 102 of 113 enrolled patients completing the study; top-line results expected in late November 2026
• Sol-Gel hosted a KOL Investor Event in New York on October 14, 2026, featuring leading dermatology experts and the Gorlin Syndrome Alliance
• U.S. commercial readiness activities for SGT-610 continue to advance ahead of a potential regulatory submission and launch

NESS ZIONA, Israel, Nov. 12, 2026 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the third quarter ended September 30, 2026, and provided a corporate update.

Q3 2026 and Recent Corporate Developments

• On September 17, 2026, Sol-Gel announced that the last patient had completed the last scheduled study visit in its pivotal Phase 3 clinical trial (SGT-610-01) of SGT-610 (patidegib gel, 2%) for the prevention of basal cell carcinoma (BCC) lesions in adult patients with Gorlin syndrome. Of the 113 patients enrolled in the randomized, double-blind, vehicle-controlled study, 102 completed the study, a completion rate of approximately 90%. The primary endpoint of the study is the number of new BCCs on the face at month 12 after twice-daily treatment. Secondary endpoints include the number of new surgically eligible BCCs (SEBs). Top-line results are expected in late November 2026.
• On October 14, 2026, Sol-Gel hosted a KOL Investor Event in New York featuring Ervin Epstein Jr., MD (Alta Bates Summit Medical Center), Kavita Sarin, MD, PhD (Stanford Cancer Institute), Elizabeth M. Billingsley, MD (Penn State College of Medicine) and Julie Breneiser, PA-C (Gorlin Syndrome Alliance). The event addressed the disease burden of Gorlin syndrome, the limitations of current surgical and off-label systemic management, and the potential role of SGT-610 in preventing the development of new basal cell carcinomas (BCCs), with the goal of reducing the need for repeated surgical interventions. A replay of the webcast and the presentation materials are available on the Investor Relations section of the Company’s website.
• Sol-Gel continues to advance its U.S. commercial readiness activities for SGT-610. If approved, the Company intends to retain full U.S. commercial rights and to commercialize SGT-610 through a cost-effective model utilizing an experienced third-party commercialization services organization, reaching the concentrated Gorlin syndrome treating population through a small, focused field organization supported by outsourced commercial infrastructure. Market access, distribution, patient support and medical affairs planning are progressing in preparation for a potential U.S. launch.

Mr. Mori Arkin, Executive Chairman of Sol-Gel, stated: “The third quarter brought us to the threshold of the most important moment in Sol-Gel’s history. Reaching last patient last visit in September marked the culmination of the patient treatment and follow-up phase of our pivotal Phase 3 trial of SGT-610, with 102 of 113 patients completing the study, representing a completion rate of approximately 90%, exceeding our original expectations for patient retention. That is a credit to the patients, investigators and site teams who stayed with us. We expect to report top-line results in late November. In parallel, we continue to advance our U.S. commercial readiness activities so that, subject to positive clinical results, we can move efficiently toward a regulatory submission and commercialization.”

Mr. Arkin further commented: “We also continue to pursue the broader opportunities for hedgehog pathway inhibition that we outlined last quarter. The studies of topical patidegib as a neo-adjuvant ahead of Mohs surgery, and for the prevention of high-frequency BCC (HF-BCC) which we announced in August, respond to interest we hear directly from surgeons, and we continue to evaluate an intra-cystic injectable for odontogenic keratocysts, a manifestation of Gorlin syndrome that often requires repeated surgical interventions. Our immediate priority remains maximizing the commercial potential of Gorlin syndrome therapy, while these additional programs are intended to expand the therapeutic applications of hedgehog pathway inhibition.”

Financial Results for the Third Quarter 2026

Revenue for the third quarter was nominal, compared to revenue of $0.4 million for the same period in 2025.

Research and development expenses were $5.1 million compared to $5.7 million for the same period in 2025. The decrease of $0.6 million was primarily attributed to a decrease in clinical trial expenses related to SGT-610.

General and administrative expenses were $1 million compared to $1 million for the same period in 2025.

Sol-Gel reported a net loss of $5.6 million for the third quarter of 2026 and loss of $1.7 per basic and diluted share, compared to a net loss of $5.9 million and loss of $2.1 per basic and diluted share for the same period in 2025.

As of September 30, 2026, Sol-Gel had $14.4 million in cash, cash equivalents, and deposits and $31.3 million in marketable securities for a total balance of $45.7 million. The Company expects its cash resources to fund cash requirements into the first quarter of 2028.

About Sol-Gel Technologies

Sol-Gel is a specialized dermatology company advancing innovative therapies for rare and serious skin diseases. Its lead investigational candidate, SGT-610 (patidegib gel, 2%), is a Phase 3, orphan- and breakthrough-designated topical hedgehog inhibitor being developed for the prevention of new basal cell carcinoma (BCC) lesions in patients with Gorlin syndrome, with the potential to offer an improved safety profile relative to oral hedgehog inhibitors. Subject to regulatory approval in Gorlin syndrome, SGT-610 may also represent a future opportunity in high-frequency BCC. Sol-Gel is also advancing SGT-210, an investigational topical EGFR inhibitor for indications with significant unmet need, and has developed two FDA-approved dermatology products, TWYNEO® and EPSOLAY®.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. including, but not limited to statements regarding the  timing of clinical milestones for the Phase 3 program of SGT-610 in Gorlin syndrome, the timing of milestones for other studies of patidegib gel, the Company’s cash runway and the future commercial activities for SGT-610. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. Forward-looking statements are based on information we have when those statements are made or our management’s current expectations and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, the risk of a delay in reporting the top-line results of Sol-Gel’s pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, that we will not successfully complete the Gorlin Phase 3 trial or that the trial will not be successful,  a delay in the planned studies of topical patidegib or that they will not be successful, higher cash burn rate than expected, that the commercialization of SGT-610, if approved, will not be as expected or successful as well as the following factors: (i) the adequacy of our financial and other resources, particularly in light of our history of recurring losses; (ii) our ability to complete the development of our product candidates; (iii) our ability to find suitable co-development partners; (iv) our ability to obtain and maintain regulatory approvals for our product candidates in our target markets, the potential delay in receiving such regulatory approvals and the possibility of adverse regulatory or legal actions relating to our product candidates even if regulatory approval is obtained; (v) our collaborators’ ability to commercialize our pharmaceutical product candidates; (vi) our ability to obtain and maintain adequate protection of our intellectual property; (vii) our collaborators’ ability to manufacture our product candidates in commercial quantities, at an adequate quality or at an acceptable cost; (viii) our collaborators’ ability to establish adequate sales, marketing and distribution channels; (ix) acceptance of our product candidates by healthcare professionals and patients; (x) the possibility that we may face third-party claims of intellectual property infringement; (xi) the timing and results of clinical trials that we may conduct or that our competitors and others may conduct relating to our or their products; (xii) intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; (xiii) potential product liability claims; (xiv) potential adverse federal, state and local government regulation in the United States, China, Europe or Israel; and (xv) loss or retirement of key executives and research scientists; (xvi) general market, political and economic conditions in the countries in which the Company operates; and, (xvii) the security situation in Israel. These factors and other important factors discussed in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 19, 2026, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Except as required by law, we undertake no obligation to update any forward-looking statements in this press release.

Sol-Gel Investor Relations:
Eyal Ben-Or
Chief Financial Officer
ir@sol-gel.com

SOL-GEL TECHNOLOGIES LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (U.S. dollars in thousands) (Unaudited)
	December 31,				September 30,
	2025				2026
Assets
CURRENT ASSETS:
Cash and cash equivalents	$	11,033			$	13,094
Marketable securities		12,966				31,324
Accounts receivable		1,968				634
Prepaid expenses and other current assets		1,004				2,462
TOTAL  CURRENT ASSETS		26,971				47,514
NON-CURRENT ASSETS:
Restricted long-term deposits and cash equivalents		1,324				1,338
Property and equipment, net		140				120
Operating lease right-of-use assets		1,027				821
Other long-term assets		62				–
Funds in respect of employee rights upon retirement		393				409
TOTAL  NON-CURRENT ASSETS		2,946				2,688
TOTAL  ASSETS	$	29,917			$	50,202
Liabilities and shareholders’ equity
CURRENT LIABILITIES:
Accounts payable	$	735			$	815
Other accounts payable		4,941				5,303
Current maturities of operating leases		495				555
TOTAL  CURRENT LIABILITIES		6,171				6,673
LONG-TERM LIABILITIES:
Operating leases liabilities		496				250
Liability for employee rights upon retirement		439				469
TOTAL  LONG-TERM LIABILITIES		935				719
TOTAL  LIABILITIES	$	7,106			$	7,392
SHAREHOLDERS’ EQUITY:
Ordinary Shares, NIS 1 par value – authorized: 5,000,000 as of December 31,  2025 and September 30, 2026; issued and outstanding: 2,786,158 and 3,276,353 as of December 31, 2025 and September 30, 2026, respectively		774				931
Additional paid-in capital		259,047				291,919
Accumulated deficit		(237,010	)			(250,040	)
TOTAL SHAREHOLDERS’ EQUITY		22,811				42,810
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	29,917			$	50,202

SOL-GEL TECHNOLOGIES LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (U.S. dollars in thousands) (Unaudited)
	Nine months ended September 30								Three months ended September 30
	2025				2026				2025				2026
REVENUE	$	18,692			$	740			$	400			$	41
RESEARCH AND DEVELOPMENT EXPENSES		19,220				11,627				5,731				5,122
GENERAL AND ADMINISTRATIVE EXPENSES		3,599				3,235				957				1,024
OPERATING LOSS		(4,127	)			(14,122	)			(6,288	)			(6,105	)
FINANCIAL INCOME,net		987				1,092				346				483
NET LOSS FOR THE PERIOD	$	(3,140	)		$	(13,030	)		$	(5,942	)		$	(5,622	)
BASIC AND DILUTED LOSS PER ORDINARY SHARE		(1.13	)			(4.16	)			(2.13	)			(1.72	)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSSPER SHARE		2,785,787				3,130,412				2,785,787				3,275,775